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Abstract 
CD4+ T cells are principal cells of the adaptive immune system, equipped with the ability to boost innate 
immune cells and aid B cells in the germinal centers. Every T cell clone carries a variable and unique T cell 
receptor that recognizes a protein-derived peptide presented on MHC molecules by antigen presenting cells 
(APC) in secondary lymphoid organs. Dendritic cells (DC) are the most prominent APC due to their 
unmatched ability to internalize foreign protein antigens, degrade them into peptides, load peptides onto 
MHC molecules and migrate to lymph nodes and present the antigen to T cells. Recognition of its cognate 
antigen leads to activation and proliferation of T cells while additional co-stimulatory signals dictate the 
differentiation and fate of T cells. Although T effector cell differentiation can be induced during the first 
encounter with an APC, the differentiation of B cell supporting T follicular helper (Tfh) cells require 
continuous antigen presentation by B cells. These two differentiation pathways of T cells occur in parallel 
and are guided by reciprocal antagonistic transcription factors. Herein, we have studied how APCs, with a 
focus on DCs and B cells, influence T cell differentiation. 
By adoptively transferring CD4+ T cells with a known antigen specificity into recipient transgenic mice in 
which DCs can be depleted we show Tfh differentiation in the absence of DCs as long as a sufficient amount 
of antigen is administered together with the adjuvant. However, depletion of DCs lead to a loss of Th1 
effector T cells that had downstream consequences on B cells by preventing class-switching into the Th1-
associated antibody isotype. Excluding the altered class-switch, germinal center B cells showed normal 
affinity maturation and memory formation. This shows that Tfh cells generated in the absence of DCs are 
fully functional and that DCs therefore do not provide unique accessory signals required for Tfh 
differentiation. 
T cells that differentiate to develop into Tfh cells become programmed to do so already during the primary 
encounter with an APC. To fulfill the Tfh differentiation program pre-Tfh cells must then interact with 
antigen presenting B cells to fully adopt Tfh functionality. This step-wise process has been extensively 
studied but it still remains unclear precisely how B cells enforce the Tfh program. In the second and third 
study, we exploited mixed bone marrow chimeras to generate mice in which B cells cannot present antigens 
to T cell thus terminating the Tfh program at the stage of T-B interactions.  
In these studies, we reveal a role of B cells in regulating T cell expression of IL-4, its receptor IL4Ra and a 
H2-Q2, a gene previously not described in T cell biology. We also show that B cells affect the output of T 
effector cells from the lymph node. In lymph, we identify T cells that exhibit phenotypic characteristics of 
Tfh cells, show a history of IL-4 secretion and are dependent on cognate B cell interactions. Some of these 
migratory ex-Tfh cells show gut tropism and can be tracked to small intestinal lamina propria. This suggests 
that Tfh cells not selected for germinal center entry can convert into tissue-tropic effector T cells.  
Keywords: T cells, T follicular helper cells, dendritic cells, B cells, germinal center, 
small intestinal lamina propria, differentiation, adaptive immunity 
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Populärvetenskaplig sammanfattning 
Trots att människokroppen konstant exponeras för virus och bakterier 
insjuknar vi sällan, tack vare vårt effektiva immunförsvar. Immunförsvaret 
består av en mängd olika specialiserade celler som delas upp i två grenar; det 
medfödda och det adaptiva immunförsvaret. Vid en infektion är det medfödda 
immunförsvaret först att aktiveras. Cellerna i det medfödda immunförsvaret 
känner igen strukturer på virus och bakterier som de inte kan förändra eftersom 
dessa är viktiga för dess överlevnad och funktion. Vissa celler inom det 
medfödda immunförsvaret har även förmågan att äta upp bakterier och 
virusinfekterade celler. Dessa celler kallas antigenpresenterande celler då de 
kan bryta ned proteiner från bakterier och virus till korta peptider som sedan 
visas upp på cellmembranet för att aktivera antigen-specifka T-celler. Det finns 
flera olika antigenpresenterande celler men dendritiska celler har visats vara 
bäst på att ta upp och presentera antigen till T-celler. 
T-celler tillsammans med B-celler utgör det adaptiva immunförsvaret. Under 
deras utveckling så klipps och klistras olika DNA-fragment ihop i de gener 
som kodar för cellernas antigen-igenkännande receptorer. Denna utveckling 
ger att varje T-cell och B-cell en receptor med unik specificitet.  Då T- och B-
celler finns i överflöd så leder denna unika igenkänning på cellnivå till att 
kroppens T- och B cells som helhet har ett väldigt brett register för 
igenkännande. Då nya T- och B-celler med olika specificeter hela tiden bildas 
för att sedan väljas och anpassas efter typen av infektion, tillhör de det adaptiva 
immunförsvaret.  
När en T-cell möter och interagerar med en antigenpresenterande cell som 
presenterar den peptidsekvens som T-cellens receptor känner igen så börjar T-
cellen att dela på sig och därmed bilda ett stort antal celler. Detta sker i 
lymfknutan och förutom celldelningen så börjar T-cellerna i lymfknutan att 
specialisera sig för att bli ännu bättre på att bekämpa infektionen. Antingen så 
lämnar de lymfknutan och beger sig till platsen för infektionshärden för att 
lokalt bekämpa den eller så stannar T-cellen i lymfknuten för att hjälpa B-
cellerna att producera antikroppar. Antikroppar är små lösliga proteiner som 
främst finns i blod och slemhinnor. Antikroppar kan bland annat neutralisera 
gifter som utsöndras från bakterier eller förhindra virus från att infektera celler. 
Precis som T-cellernas receptor har antikropparna en unik specifictet. Om B-
cellernas receptorer som utgörs av cellmembransbundna antikroppar känner 
igen ett protein har de möjlighet att ta upp proteinet och presentera peptider för 
T-cellerna. På så sätt kan B-celler agera som en antigenpresenterande cell för 
T-celler. B-celler som visar upp antigen för T-celler kan sedan med hjälp av T-
  
celln att förbättra de antikropparna som de producerar och på så sätt förstärka 
immunförsvarets effekt. 
Denna avhandling är baser på mina studier om hur olika antigenpresenterade 
celler, främst dendritiska celler och B-celler, vägleder T-cellernas beslut att 
antingen stanna i lymfknutan eller att bege sig till infektionshärden. Arbetet är 
utfört i olika musmodeller där vi genom genetiska manipulationer kan 
eliminera vissa celler eller där B-celler inte längre har förmågan att presentera 
antigen till T-celler. Vi fann att dendritiska celler har en unik förmåga att 
inducera typ-1-immunsvar men att de inte är umbärliga för att hjälpa B-celler. 
Vi visar även visat att B-celler även kan påverkar vilka T-celler som beger sig 
till infektionshärden. Dessa studier bidrar en bättre förståelse för hur B-celler 
och dendrtitiska celler påverkar T-cellernas funktioner. Kunskap om hur man 
kan styra T-celler till infektionshärden eller uppmuntra dessa att stanna kvar i 
lymfknutan för att hjälpa B-cellernas antikroppsproduktion är av stort värde 
för utvecklig av nya vaccin.
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The cells and anatomical organization of the 
immune system 
The immune system is composed of numerous different cell types, each 
providing a highly specialized function. The survival of an organism is directly 
dependent on its immune system and its capacity to provide immunity. The 
immune system is compartmentalized into separate sites where immune cells 
are generated, mature, become activated and where they perform their 
function. In this section I will briefly introduce the principal cells of the 
immune system, lymphoid organs and peripheral effector sites. 
Cells of the immune system 
The immune system is generally divided into the innate and the adaptive 
immune system. The innate, or in-born, immune system is the first line defense 
against invading pathogens acting instantly upon pathogen encounter. The 
cells of the innate immune system are activated either by effector molecules 
provided by other cells or directly by invariant pattern recognition receptors 
(PRRs). The PRRs recognize evolutionary conserved elements with limited 
variability called pathogen-associated molecular patterns (PAMPs). These 
structural components are essential for survival of the microbe. A family of 
receptors called Toll-like receptors (TLRs) are the most studied PRRs. TLRs 
are capable of recognizing bacterial structures like lipopolysaccharide and 
lipoteichoic acid, but other TLRs also sense double-stranded RNA (dsRNA) 
found in viruses, thus allowing the innate immune system to identify the type 
of invading pathogen (1). 
Some innate immune cells, called granulocytes (neutrophils, eosinophils, 
basophils and mast cells), contain intracellular granules loaded with pro-
inflammatory molecules and effector molecules capable of killing pathogens 
(2). In response to activation signals, granulocytes rapidly degranulate and 
initiate the immune response by causing inflammation of the tissue. 
Phagocytes are cells capable of ingesting and killing whole bacteria targeted 
for phagocytosis by the complement system and antibodies or following 
recognition of PAMPs (3). Phagocytes include neutrophils and mast cells of 
the above-mentioned granulocytes as well as macrophages and dendritic cells 
(DCs). Natural killer (NK) cells are specialized in killing virus infected cells 
by secretion of pore forming molecules and proteases which in combination 
lyse the target cell. Typically, NK cells target cells that fail to express MHC 
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class 1 molecules (4), or by binding of CD16 (FcRgIII) to the Fc-region of an 
antibody bound to the target cell which initiate killing through antibody-
dependent cellular cytotoxicity (ADCC) (4, 5). 
Whereas the innate immune system recognizes conserved elements present on 
the surface or cytoplasm of microbes, the adaptive immune is highly specific 
to non-conserved, or variable, elements. The cells of the adaptive immune 
system have several important functions for overall immunity. B cells produce 
antibodies that can neutralize toxins, activate complement or target cells for 
phagocytosis and ADCC. T cells, given their name due to their thymus 
dependent maturation, are subcategorized into CD4+ T cells and CD8+ T cells. 
The CD4+ T cells are called T helper cells and play an essential role in 
promoting immune responses by producing cytokines that acts upon 
surrounding cells. CD8+ T cells, or cytotoxic T lymphocyte, induce lysis in 
virus-infected cells or altered self (i.e. cancer) in an antigen dependent manner. 
Additional cells of the adaptive immune system are NKT cells, mucosal 
associated invariant CD8+ T cells and gd T cells that recognizes conserved 
structure like lipids and bacterial metabolites, giving them innate-like 
properties in terms of antigen recognition.  
The adaptive immune system has several distinct functions that are not shared 
by the innate immune system. First, cells of the adaptive immune system are 
able to proliferate in response to antigen recognition, thus amplifying the sheer 
number of reactive cells. Second, by recombination of the germline DNA 
encoding their receptors they are capable of generating an almost limitless 
number of receptors, all with unique specificity. In the case of B cells these 
receptors can be mutated in activated cells to further increase specificity, or 
affinity (6, 7). Lastly, antigen experienced cells are capable of surviving for 
extended periods of time. These cells potently and rapidly respond upon re-
exposure to their cognate antigen (8, 9), thus providing immunological 
memory which is the basis of vaccines. 
The link between the innate and adaptive immune system is facilitated by cells 
that are capable of taking up foreign protein antigens, degrade them into 
peptides and present them on major histocompatibility complexes (MHC) for 
T cell recognition. Cells capable of performing this critical function, called 
antigen presenting cells (APCs), are found throughout the body scanning the 
tissue for foreign antigen. Cells with antigen presenting function include DCs 
(conventional and plasmacytoid), B cells, macrophages and monocytes. The 
conventional DCs (cDCs) are considered to be the most proficient APC in 
terms of antigen uptake, presentation and activation of T cells. 
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The key cells for induction of antibody mediated immune responses, CD4+ T 
cells, DCs and B cells, are central to this thesis and will be covered in full in 
the coming chapters.  
Primary lymphoid organs 
The immune system can be compartmentalized into three anatomical distinct 
regions. The primary lymphoid organs constitute the first of these sites and are 
responsible for the generation and development of immune cells. 
The bone marrow 
The immune cells outlined in the previous section are all of hematopoietic 
origin and generated in the bone marrow (BM). All cells derived from a shared 
stem cell precursor that through activation of transcription factors gradually 
guiding their differentiation into separate lineages (Figure 1). The first distinct 
separation arising from the shared BM stem cells is the differentiation into 
either a common myeloid precursor or a common lymphoid precursor. With 
the exception of NK cells, innate immune cells develop from the common 
myeloid precursor through several intermediary steps and, conversely, NK 
cells, B cells and T cells are derived from the common lymphoid progenitor.  
Some of the cells complete their maturation in peripheral tissues, T cells 
however, exit the BM as progenitor thymocytes and require further 
development in the thymus to become mature T cells. 
Thymus 
Thymus is the primary lymphoid organ responsible for development and 
selection of T cells. The important role of the thymus in generating T cells was 
discovered by surgical removal of the thymus. Athymic mice lack T cells and 
fail to reject skin and tumor engraftments (10). The course of T cell 
development is guided by sequential interactions between different thymic 
epithelial cells, DCs and the maturing T cells to ensure generation of functional 
and non-self-reactive T cells. The process of T cell development in thymus will 
be described in greater detail in the T cell section.  
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Figure 1. Overview of haematopoiesis. HSC: Haematopoietic stem cell, CMP: 
Common myeloid progenitor, CLP: Common lymphoid progenitor, GMP: 
Granulocyte / Macrophage progenitor, CDP: Common DC precursor 
Secondary lymphoid organ 
The secondary lymphoid organs (SLOs) are strategically situated to monitor 
pathogenic infiltration at all tissues throughout the body. SLOs are connected 
to blood vessels and the lymphatic system. The lymphatic system connects the 
tissue to SLOs via afferent lymphatics through which free antigen as well as 
antigen bearing cells are transported into the SLOs. Lymphocytes exiting SLOs 
migrate through efferent lymphatics and via ducts emptied back into the blood 
stream. This allows lymphocytes to circulate through SLOs in search of APCs 
that present antigens from peripheral tissues. Thus, SLOs serve as a focal point 
facilitating the encounter between APCs and T cells and therefore function as 
inductive sites for the adaptive immune system.   
The spleen 
The spleen is not connected to afferent lymphatics, instead it is dedicated to 
scan for antigens in the blood stream, degrade aging erythrocytes and iron 
recycling (11). The spleen is anatomically divided into two large 
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compartments, the red pulp and the white pulp which are encapsulated by the 
marginal zone. In the red pulp the blood is filtered from old erythrocytes and 
iron is recycled. This is also the site for lymphocyte entry and a reservoir for 
antibody producing plasma cells (PCs) as well as monocytes (11, 12). The 
marginal zone is rich in DCs and macrophages proficient in acquiring blood 
borne antigens. A population of B cells (marginal zone B cells), that are 
important for early immune responses by recognition of conserved microbial 
elements also resides within the marginal zone (13).  
Closest to the central arteriole in the white pulp lies the periarteriolar sheath, 
forming an area that is populated by T cells and DCs. Situated in-between the 
periarteriolar sheath and the marginal zone follicles containing B cells can be 
found. The distinct separation between T and B cells areas is maintained by 
the secretion of chemokines from fibroblastic reticular cells in the T cell zone 
and follicular dendritic cells (FDCs) in the B cell follicle (11). In addition to 
the acquisition of antigens via macrophages and DCs in the marginal zone, a 
conduit system that runs throughout the white pulp allows for transport of 
smaller sized antigens that can be sampled by DCs (14). In contrast to lymph 
nodes (LNs), the spleen does not have efferent lymphatics. Instead lymphocyte 
egress from the spleen directly into the blood stream, most likely by initial 
transit from the white pulp into the red pulp via bridging channels in the 
marginal zone (15). 
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Mesenteric lymph nodes 
The mesenteric lymph nodes (MLNs) are the second line of SLOs (Figure 2) 
and drain the intestine and efferent lymphatics from Peyer´s patches. Small 
molecular antigens that enter the MLN via the afferent lymphatics is 
distributed by a conduit network similar to that seen in spleen (16). Antigen-
bearing DCs arrive to the MLN via afferent lymphatics and then enter at the 
subcapsular sinus. The DCs then translocate into the cortex where B cells 
reside and then proceed to venture further into the paracortex, the T cell zone 
of the MLN. T and B cells as well as LN resident DCs enter LNs via high 
endothelial venules (HEVs). Lymphocytes are able to transmigrate into the 
MLN via HEVs by binding of CD62L, LFA-1 and CCR7 to PNAd, ICAM-1 
and CCL-21, respectively, present on the HEV endothelium (17-21). MLNs 
and other gut-associated SLOs also express the mucosal vascular addressin 
MAdCAM-1 that bind to the gut-homing associated integrin a4b7 (22, 23). 
Furthermore, MAdCAM-1 acts as a ligand for CD62L if properly glycosylated, 
thereby adding additional means of entry for lymphocytes (24, 25).  
Figure 2. The anatomical organization of a lymph node 
The mucosal immune system 
Mucosal surfaces cover all internal body surfaces and are constantly exposed 
to both pathogens and commensal bacteria. Maintenance of its integrity is 
therefore essential for the survival of the organism. In addition to physical and 
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chemical barriers, it requires a finely tuned immune landscape able to combat 
invading pathogenic microorganisms yet adequately handle harmless food-
antigens and commensal bacteria.  Herein, I will focus on the mucosal immune 
system and its associated structures. 
Peyers´ Patches 
Interspersed along the intestine, just underneath the epithelium, lies several 
highly organized clusters of lymphoid follicles called Peyer´s patches (PP) that 
serves as the primary induction sites for immune responses in the gut. Due to 
the anatomical localization, PPs lack afferent lymphatics and the efferent 
lymphatics connect to MLNs rather than emptying into the blood stream. The 
epithelial layer of the PP that separates the underlying subepithelial dome 
(SED) and the gut lumen is called follicle-associated epithelium (FAE). 
Lodged in the FAE are microfold (M) cells that can transport luminal antigens 
and microbes into the SED (26, 27). In the SED, DCs acquire antigens and 
migrate from the SED to the neighboring T cell zone to initiate T cell responses 
(28, 29). In contrast to other SLOs, entry of lymphocytes into PPs via HEV do 
not rely on CD62L expression as PP-associated HEVs lack expression of 
PNAd (17). 
Isolated lymphoid follicles & cryptopatches 
Cryptopatches (CP) and isolated lymphoid follicles (ILFs) are small solitary 
follicle like structures encircled by DCs that are present directly underneath 
the epithelium containing M cells in the small intestine (30). The CPs consists 
of lineage negative lymphoid cells expressing the stem cell factor c-kit (31) 
whereas the ILFs contain mostly B cells (32). Whether these structures can, 
similar to other SLOs, function as inductive sites for conventional T cells is 
still not known.   
Small intestinal lamina propria 
The small intestine is comprised of a monolayer of epithelial cells forming 
crypts and villi lined with mucus on the luminal side. Together the epithelial 
cells and the mucus constitute both a physical and a chemical barrier against 
the gut microbiota. The underlying tissue, separated by a thin layer of 
extracellular matrix, is the small intestinal lamina propria (SI LP). The SI LP 
serves as one of the main effector sites of mucosal immune responses. LP DCs 
are able to acquire gut luminal antigens by transepithelial sampling (33, 34), 
or acquire antigens via M cells that actively transport antigens across the 
epithelium (35). The LP do not function as an inductive site and therefore 
antigen bearing DCs migrate to the MLN via the lymphatic system in an 
CCR7-dependent manner in order to encounter naïve T cells (36, 37). Efficient 
homing to the SI LP of lymphocytes require expression of a4b7 integrin that 
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binds to the addressin MAdCAM-1 present on post-capillary venules in the SI 
LP (22, 23). Furthermore, expression of the chemokine receptor CCR9 can 
help facilitate gut-homing and transmigration in response to CCL25 produced 
in the SI LP and presented on the apical surface of the endothelium (38-40). 
However, the importance of CCR9 expression for gut-homing is not uniform 
for all cell types as CCR9 deficient CD4+ T cells are not as disadvantaged in 
their gut-homing as their CD8+ counterparts (41, 42). 
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Dendritic cells 
Discovered in the early 1970´s by Steinman and Cohn, DCs were given their 
name due to their morphological shape of dendrites extending from the cellular 
body (43-45). The findings that DCs express PRR and are able to induce T cell 
proliferation in vitro identified DCs as a link between the innate and adaptive 
immune system (46, 47). This role has been further solidified over the years 
and DCs are now considered to be the supreme APCs. This is attributed to their 
unique ability to migrate from the peripheral tissue into the SLO via lymphatic 
vessels in combination with their unparalleled potency to induce responses in 
naïve T cells (48-50). 
Dendritic cell subsets 
DCs are commonly divided into four categories based on their distinct function 
and tissue localization, namely conventional DCs (cDCs), plasmacytoid DCs 
(pDCs), Langerhans cells and monocyte-derived DCs (moDCs) (51).  The term 
“DCs” often refers to cDCs as they are the most common of the four. Most 
frequently identified by expression of CD11c and MHCII, cDCs are present in 
SLOs as well as at effector sites.  Immature cDCs exhibit phagocytic activity, 
abundant expression of PRRs and intermediate expression of MHCII and 
CD11c (52). In response to activation by PRR triggering, cDCs mature, halt 
their phagocytic activity and upregulate MHCII and co-stimulatory molecules 
to increase the capacity to activate T cells (52). Furthermore, cDCs at effector 
sites upregulate CCR7 and migrate to SLOs via the lymphatic system in a 
CCR7 dependent manner (36, 37). cDC are subcategorized into subsets based 
on their expression of transcription factors, surface markers and associated 
differential functionality. Murine migratory cDCs expressing CD103 but not 
CD11b have the ability to present extracellular antigens to CD8+ T cells in 
what is called cross-presentation, whereas migratory CD11b+ cDCs are more 
proficient in inducing CD4+ T cell responses (53, 54). In comparison, LN 
resident cross-presenting cDCs do not express CD103, rather they are 
commonly distinguished by CD8a expression (55, 56). Similarly to migrating 
CD103+ cDCs, CD8a+ cDCs are less proficient inducers of CD4+ T cell than 
the LN resident CD11b+ cDCs (56, 57). A study by Watchmaker et al 
characterized human cDC subsets and found that SI-LP SIRPa+ CD103+ cDCs 
and blood CD1c+ cDCs correlated to murine SI LP CD11b+CD103+ cDCs (58). 
Moreover, they found that CD11b-CD103+ cDCs in murine SI LP 
corresponded to human SI LP SIRPa- CD103+ and blood CD141+ cDCs (58). 
Due to the discrepancy in surface marker expression between species, the two 
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major subsets of cDCs have now been termed cDC1 (CD141+/CD103+) and 
cDC2 (SIRPa+/CD11b+). While all cDCs share expression of the transcription 
factor Zbtb46 (59, 60), lineage defining transcription factors promoting cDC1 
and cDC2 development have been identified. Initially, the transcription factor 
Batf3 was found to be critical for cDC1 development (61). However, Batf3-/- 
mice was shown to develop cDC1s during infection via a Batf3-independent 
pathway (62) calling into question whether all cDC1s depend on Batf3 for their 
development. In addition to Batf3, the transcription IRF8 have now been 
shown to be critical for development of both LN resident and SI LP cDC1s 
(63, 64). Regarding cDC2s, no single transcription factor have been identified 
to be absolutely critical for their development although mice deficient in either 
Notch2 or IRF4 show dramatically decreased numbers in both peripheral tissue 
and LN resident cDC2s (65, 66).  
Preferentially present in spleen, SLOs, liver and bone marrow, pDCs are 
morphologically spherical and unable to migrate via the lymphatic system (67, 
68). In experiments using targeted antigen delivery to pDCs via CD303 and 
DCIR have shown that they are able to act as APCs and induce CD4+ T cell 
responses (69, 70). While certainly able to present antigen and induce T cell 
responses, their specialization lies in their capacity to produce vast amounts of 
type I interferons in response to PRR signaling, mainly through TLR7 and 
TLR9 (71).  
Langerhans cells reside in the ectodermal tissue and dermis of the skin. They 
share the migratory trait of cDCs and are able to present and antigens and also 
transfer antigens to cDCs. Langerhans cells are of myeloid origin but they 
renew independently of the BM from tissue resident progenitors (72). Genetic 
tracing experiments also show that Langerhans cells unlike DC precursors, do 
not express the C-type lectin receptor 1 (DNGR-1) thus questioning if 
Langerhans cells truly can be classified as a bona-fide DC subset (73). 
The last type of DC is the inflammatory monocyte derived DC (moDC) that 
stems from the macrophage DC progenitor in the BM. Monocytes 
constitutively seed into tissues as Ly6Chigh monocytes and differentiate into 
two populations, CX3CR1+ CD64+ macrophages and moDCs. In the SI LP, 
these macrophages are situated underneath the epithelium and able to extend 
their dendrites through the small intestinal epithelium into the gut lumen to 
sample antigens (74) but do not migrate and inefficiently prime T cells (75). 
During inflammation, the influx of Ly6C+ monocytes dramatically increases 
(76, 77) and transition of monocytes to moDCs is marked by high expression 
of CD11c and MHCII, which in combination with intermediate expression of 
CX3CR1 and lack of CD64 distinguish them from CX3CR1+ CD64+ 
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macrophages (76, 78). In contrast to CX3CR1+ CD64+ macrophages, moDCs 
are migratory (54, 76, 79) and have been shown to produce IL-6 and promote 
germinal centre responses in the context of CpG immunization (80). 
Antigen uptake and presentation on MHCII 
The most unique role of APCs is their ability to internalize extracellular 
antigens that are subsequently degraded into peptides. The peptides are then 
loaded onto MHCII molecules for recognition by the T cell receptor of CD4+ 
T cells, or CD8+ T cells by MHCI for cross-presentation (81). cDCs exploit 
various cellular processes to acquire antigen and deliver them into antigen-
processing compartments (see below). The antigen-processing compartments, 
typically late endosome or lysosomes with an acidic environment, contain 
proteolytic enzymes and newly produced MHCII molecules loaded with 
invariant chain (Ii) that must be proteolytically degraded to disassociate from 
the MHCII molecule (82-84). When Ii is cleaved, a small peptide fragment 
called class II-associated invariant chain (CLIP) remains bound to the peptide 
binding groove of the MHCII molecule.  By the aid of the chaperone H2-M, 
CLIP is substituted to the peptide to be presented and subsequently transported 
to the cell surface for CD4+ T cell recognition (82).  
There are four principal mechanisms by which cDCs and other APCs utilize to 
attain antigen into antigen-processing compartments for MHCII loading. First, 
an unspecific process called macropinocytosis enables cDCs to sample their 
surroundings for antigen by internalizing part of their cell membrane into 
endosomes. This process is carried out in a constitutive manner in immature 
cDCs and activation, or maturation, by PRR stimuli leads to a temporary burst 
of macropinocytosis activity that wanes after a few hours (85, 86). 
Second, APCs can internalize antigens via receptor-mediated endocytosis via 
the complement receptors, Fc receptors or lectin receptor like DEC205 that 
recognize carbohydrate structures on proteins and pathogens. In the case of B 
cells, the B cell receptor (BCR) function as an antigen specific endocytic 
receptor. These receptors help facilitate the uptake of antigen into antigen-
processing compartments in both clathrin-dependent and independent manners 
and, at least for the clathrin-dependent endocytosis, the aptitude of receptor-
mediated endocytosis in cDCs persists after activation (87). Due to the efficient 
uptake of antigen into antigen-processing compartments, receptor-mediated 
endocytosis has been exploited in several experimental systems by conjugation 
of antigen to antibodies specific for endocytic receptors (88, 89). 
 12 
Third, phagocytosis of bacteria and apoptotic cells is probably the most 
important mechanisms of antigen uptake employed by APCs as it leads to both 
effector T cell responses but also supports the induction of tolerance against 
self-derived antigens (90, 91). Similar to receptor-mediated endocytosis, 
phagocytosis is primarily induced by binding to receptors, some of which are 
shared between the two mechanisms like Fc and complement receptors. 
Following internalization of particulate antigens the phagosome fuses with 
lysosomes to create a phagolysosome that contains enzymes that can kill the 
pathogen and degrade its proteins for loading on MHCII molecules (90). While 
cDCs efficiently phagocytose bacteria and apoptotic cells to present antigens, 
macrophages have a lysosome-dominant endocytic compartment better suited 
for the killing of pathogens (92). 
The final mechanism for MHCII presentation is the presentation of cytosolic 
and nuclear antigens by autophagy. During autophagy, the autophagosome 
devour macromolecules and organelles and merges with endosome and 
lysosome containing the MHCII loading machinery to form the 
autophagolysosome (93, 94). This process is seemingly important for 
presentation of self-antigens and is therefore of utmost importance during T 
cell selection in the thymus (95, 96). 
T cell interactions 
The purpose of antigen presentation by APCs is to initiate T cell responses. 
cDCs are considered to be the supreme APCs for this task as they are most 
proficient in capturing, processing and present antigens both on MHCII and 
cross-presenting extracellular antigens on MHCI (81, 97, 98). The current view 
of T cell activation conventionally comprises of three signals needed to fully 
activate a T cell and guide their differentiation. All of these signals can be 
provided by cDCs. Signal 1 is the interaction between the TCR and its cognate 
peptide presented on MHC complexes, which triggers TCR signaling via CD3. 
However, this signal in the absence of signal 2 consequently lead to an 
unresponsive state or T cell anergy (99).  
Signal 2 is delivered by interactions of co-stimulatory molecules present on the 
cell surface of APCs and their corresponding ligands on the T cells. Immature 
cDCs express low levels of co-stimulatory molecules and surface expression 
is readily upregulated upon cDC maturation by PRR signaling induced by 
PAMPs like dsRNA, LPS and unmethylated CpG DNA-motifs binding to 
TLR3, TLR4 and TLR9, respectively (100-102). DCs express several co-
stimulatory molecules, the best described are CD80 and CD86 that bind to 
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CD28 on T cells.  In combination with CD3 stimuli these co-stimulatory 
molecules are sufficient to induce T cell proliferation and IL-2 production in 
vitro (103, 104). The function of CD80 and CD86 is not only of stimulatory 
nature as T cells during the later stages of T cell activation express another 
ligand, CTLA-4, that transduces inhibitory signals to downregulate T cell 
responses. Consistent with the findings that co-stimulatory molecules are 
upregulated upon maturation it has been shown that T cell priming by 
immature DCs primarily generates regulatory T cells and not effector T cells 
(105, 106). Moreover, cDCs can also express co-inhibitory molecules like 
programmed death-ligand 1 (PD-L1) that consequently leads to reduced T cell 
proliferation and production of the suppressive cytokine IL-10 (107, 108).  
The 3rd and final signal is mediated by soluble factors called cytokines. Just 
like the cell-surface bound co-stimulatory molecules, the production of 
cytokines is induced in response to PRR signalling (100-102). In combination 
with the signals provided by co-stimulatory molecules, cytokines help to shape 
the outcome of T cell responses by modulating expression of transcription 
factors. In the next chapter I will in-depth describe the role of cytokines and 
co-stimulatory molecules in regulating T cell responses. 
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T cells 
T lymphocytes, or T cells, were given their name due their thymus dependent 
development. T cells represent one of the two cell types that constitute the 
adaptive immune system. In contrast to the cells of the innate immune system 
which recognize conserved moieties and structures by PPRs, the reactivity of 
T cells is determined by their TCR that recognize variable protein derived 
peptides. The majority of T cells are conventional T cells of either CD4+ or 
CD8+ lineage, each carrying a unique TCR composed by pairing of a TCRa- 
and TCRb-chain. TCRs of conventional CD8+ and CD4+ T cells recognize 
peptides from degraded proteins presented on MHC class I and II molecule, 
respectively.  
While CD4+ T cells are restricted to interact with a limited number of cells 
capable of presenting peptides originating from the endosome compartment on 
MHCII, as discussed in the previous chapter, CD8+ T cells recognizes peptides 
from the cytosolic compartment presented on MHCI on all nucleated cells. 
CD8+ T cells are commonly referred to as cytotoxic T lymphocytes (CTLs) 
due to their cytolytic (“killing”) activity in response to antigenic stimuli after 
initial, antigen dependent, activation by cross-presenting DCs in SLOs. 
Mechanistically, CTLs induce apoptosis in target cells displaying their cognate 
peptide-MHCI complex, by secretion of perforin and granzyme B which form 
a pore in the target cells or via FAS-FASL interactions (109). Their ability to 
selectively induce apoptosis in cells in a controlled manner makes CTLs 
instrumental in combating virus infections as well as eradicating tumor cells 
displaying altered-self peptides.   
Another set of lymphocytes that do not recognize peptide antigens, consisting 
of mucosa-associated invariant T (MAIT) cells, natural-killer T cells and gd T 
cells which do not use the TCRa and TCRb-chains, also develop in the thymus. 
Unlike conventional T cells these lymphocytes do not respond to peptides 
presented on MHC molecules but rather recognize bacterial metabolites, 
glycolipids and lipids presented on MR-1 and CD1d molecules. Based on the 
scope of this thesis, the following section will focus its discussion on CD4+ T 
cells, their development, differentiation process and function.  
Development and thymic selection 
Deriving from the common lymphoid progenitor in the BM, T cell precursors 
exit the BM and through the blood stream enter the thymus, an organ 
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specialized for the purpose of T cell development. Once in the thymus, T cell 
precursors start to proliferate to generate a pool of thymocytes and the process 
of T cell maturation is initiated. The T cell “rite of passage” begins with 
rearrangement of the TCRb locus to successfully generate a unique TCR 
capable of recognizing antigens. In short, the TCRb locus consists of 52 
different Vb gene segments, 2 Db gene segments and 13 Jb gene segments. By 
the aid of two endonuclease enzymes called RAG-1 and RAG-2 two random 
Db and Jb gene segments are juxtaposed thus forming a hairpin loop of DNA 
which is separated from the chromosomal DNA by RAG1/2 (110). In order to 
complete the ligation of the two Db and Jb gene segments another set of 
enzymes is involved. One of the enzymes involved, TdT, randomly removes 
or inserts nucleotides in the ends of the cleaved Db and Jb gene segments and 
once matching ends are generated the two segments are joined together (111). 
To complete the TCRb chain rearrangement the newly generated DJb segment 
is paired to one of the 52 different Vb segments by the same mechanisms 
described above.  
When thymocytes successfully have recombined a TCRb chain capable of 
pairing with a surrogate TCRa chain to form a pre-TCR they rapidly 
proliferate and acquire expression of both CD4 and CD8 molecules. The CD4+ 
CD8+ thymocytes are commonly referred to as “Double-positive thymocytes” 
and it is during this stage of development that the rearrangement of the TCRa 
chain locus is initiated. Distinct from the TCRb locus, the TCRa locus is 
comprised of approximately 70-80 Va and 61 Ja gene segments and lack D 
segments altogether. Mechanistically, Va and Ja genes are joined together as 
described above but the lack of D segment and surplus of Va and Ja segments 
allows for continuous rearrangement of the TCRa locus, until a TCR capable 
of weakly recognizing self-peptide:self-MHC is generated.  
The recognition of self-peptide:self-MHC complexes is the most critical aspect 
of the T cell development as this checkpoint serves as a double-edged sword 
in what is known as T cell selection. First, the TCR must be able to bind self-
peptide:self-MHC complexes on cortical thymic epithelial cells (cTECs). This 
ensures that the T cell is reactive to peptides presented on self-MHC molecules. 
Failure to do so results in apoptosis of the T cell and this process is known as 
positive selection (112). T cells that successfully pass the positive selection 
migrate from the cortex into the medulla. Secondly, the TCRs are screened for 
self-reactivity in the medulla where they encounter medullary thymic epithelial 
cells (mTECs) and thymic DCs that present a vast array of self-derived 
peptides. If the TCR binds to any of the numerous self-peptide:self-MHC 
complexes presented with too high affinity they will undergo apoptosis or gain 
immunosuppressive properties. This mechanism is known as negative 
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selection and serves as an effective way of purging potentially self-reactive T 
cells that otherwise could cause autoimmunity (112). At this stage T cells lose 
expression of either CD4 or CD8 depending on if they recognize MHCII or 
MHCI molecules, respectively. The T cells have thereby completed the 
maturation process and enter the blood stream as naïve T cells.  
All in all, the enormous number of possible combinations between gene 
segments and junctional diversity caused by TdT have the potential to give rise 
to a seemingly infinite number of T cells, each carrying a TCR with unique 
specificity. However, the safe-keeping mechanisms in play during the multi-
stage process of thymic selection renders only a small fraction of the 
thymocytes to mature into functional naïve T cells. 
CD4 T helper cell activation and differentiation 
Once CD4+ T cells have fulfilled their thymic selection they relocate from the 
thymus to SLOs via the blood stream. After entry into SLOs, T cells position 
themselves in the T cell zone in response to a CCL19/21 gradient by the 
chemokine receptor CCR7. At this stage, CD4+ T cells are considered to be 
naïve, meaning that they are antigen inexperienced i.e. have not received the 
signals needed to become activated. These signals can only fully be delivered 
by APCs. The activation of CD4+ T cells is often considered to require, and be 
influenced by, three distinct signals. The first signal, or signal 1, is recognition 
of the cognate antigen presented on MHCII molecules on APCs by the TCR. 
Signal 2 is comprised by the interactions of co-stimulatory, or co-inhibitory, 
molecules present on APCs and their ligands on T cells. Signal 1 and 2 are 
minimum requirements for activation of T cells and proliferation, while signal 
1 in the absence of signal 2 leads to anergy. Finally, signal 3 is a polarizing 
signal mediated by soluble cytokines which promotes differentiation into 
distinct subsets, each uniquely specialized in propagating immune responses 
tailor-fitted to fend off the specific pathogen. Each of these specialized subsets 
produce a defined set of effector molecules and their differentiation is 
governed by a master transcription factor (Figure 3).  
Effector cells 
Initially, CD4+ T cell responses were considered to solely be composed of type 
1 T helper (Th1) and type 2 T helper (Th2) cell subsets based on their distinct 
production of cytokines as described by Mosmann and Coffman (113). Later, 
additional T cell subsets have been discovered, of which the type 17 helper 
(Th17) cell is the best described. This makes it evident that CD4+ T cell 
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differentiation is more complex than a binary choice between Th1 and Th2 
subsets.  
The differentiation and function of Th1 cells is governed by the transcription 
factor T-bet, encoded by the gene Tbx21, which is induced in response to 
interferon g (IFNg) signalling via signal transducer and activator of 
transcription 1 (STAT1) (114, 115). In turn, T-bet drives the expression of the 
IL-12b receptor (115) which allows IL-12 signalling through STAT4 to further 
support T-bet expression thus establishing a step-wise positive feedback loop 
underlining the importance of IL-12 and STAT4 signalling in Th1 
differentiation  (116-119). Additionally, IL-18 and IL-27 have also been 
reported to be beneficial for Th1 differentiation as Th1 responses are reduced 
in mice deficient for either cytokine (120-123). Once established, T-bet drives 
the expression of the Th1 associated effector molecules IFNy and tumor 
necrosis factor a (TNFa) which are potent inducers of macrophage activation 
and the cellular defence against viruses and intracellular bacteria.  
Th2 cells, on the other hand, are dependent on the transcription factor GATA3 
for their differentiation (124, 125) hence GATA3 deficient mice entirely fail 
to generate Th2 cells (126, 127). Early in vitro findings showed that the early 
IL-4 production is dependent on IL-2 signalling via STAT5 (128, 129) which 
together with GATA3 have been reported to bind the DNase I hypersensitivity 
site II in the Il4 promoter (129, 130), a site which strongly regulates IL-4 
expression in Th2 cells. STAT5 signalling also induces expression of the IL4R 
a chain (131), making T cells responsive to  IL-4 signalling through STAT6. 
This manifests GATA3 expression and the Th2 differentiation program (132-
134). Although the IL-4 and STAT6 signaling axis are required for Th2 
induction and worm expulsion during Trichuris muris infection (135), it has 
been shown both IL-4 and STAT6 deficient animals can support the GATA3 
dependent development of Th2 cells (136-138). This suggests that an IL-4 
independent pathway towards Th2 generation also exist.  
The effector functions of Th2 cells mediate immunity towards extracellular 
parasites, like nematodes and helminths, but also promote allergic and 
asthmatic responses. Functionally, these responses are facilitated by GATA3 
reinforced production of the Th2 signature cytokines IL-4, IL-5 and IL-13, 
which recruit and activate eosinophils to degranulate effector molecules 
capable of killing parasites (139). Besides acting on eosinophils to expel or kill 
parasites, the cytokines produced by Th2 cells can also support antibody 
isotype class-switching into IgG1 and IgE. Cross-linking of IgE bound to high-
affinity FceRI receptors on mast cells induced by antigen binding causes 
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degranulation releasing histamine and pre-stored TNFa. This will promote 
inflammation but also augment rapid allergic and asthmatic responses.  
The Th17 subset was the third subsets of effector T cells to be described, 
thereby upending the Th1 vs Th2 paradigm. One of the canonical Th17 
cytokines, IL-17A of the IL-17 cytokine family, was early known to enhance 
immunity towards extracellular pathogens as well as to be associated with 
autoimmunity but the regulation of IL-17 expression remained unknown. The 
findings that cells expressing IL-17 could not co-express either IFNg or IL-4 
when primed in the presence of microbial lipopeptides (140) sparked the idea 
that a third subset of effector T cells might exist. Follow-up studies in 
autoimmune mouse models showed that ICOS and IL-23 were critical for IL-
17 but not IFNg expression (141-143). In 2005 two groups also showed that 
IL-17 producing cells develop independently from Th1 and Th2 cells (144, 
145). While these studies used IL-23 to polarize IL-17 producing T cells it was 
shown IL-23 was not necessary in vivo for early Th17 differentiation as the 
proliferative effects of IL-23 was intact in Th17 cells derived from IL-23 
deficient mice (146). Later, several studies identified IL-6 and transforming 
growth factor b (TGFb) as the cytokines involved in early Th17 differentiation 
in the absence of IL-23 (147-149).  
The master transcriptional regulator of Th17 was identified in 2006 when 
Ivanov and colleagues observed that the transcription factor RORgt was 
induced in response to TGFb and IL-6, promoted Th17 responses when 
overexpressed and conversely showed defective Th17 responses in RORgt 
deficient cells (150). While TGFb signalling inhibits SOCS3, a suppressor of 
STAT3, to promote Th17 responses (151), IL-6 stimulation leads to 
phosphorylation and activation of STAT3, which is crucial for Th17 
development by regulating expression of RORgt (152, 153). In addition, the 
activation of STAT3 leads to production of IL-21. This enforces the Th17 
phenotype by initiating a self-regulated positive feedback loop via IL21R and 
STAT3 to sustain Th17 phenotype and function (154-156). The pro-
inflammatory cytokines secreted by Th17 cell (IL-17A, IL-17F, IL-22, IL-6 
and TNFa) typically leads to release of chemokine involved in recruiting 
neutrophils, monocytes and production of anti-microbial peptides (157, 158). 
Finally, it was demonstrated in mice that the presence or absence of segmented 
filamentous bacteria in the intestinal commensal flora was directly linked to 
the increased Th17 responses and resistance to Citrobacter rodentium infection 
in the host (159). Conversely, the same model was also used to illustrate the 
ability of Th17 cells to promote arthritic autoimmunity (160), thus illustrating 
the whole spectra of Th17 mediated immunity.  
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Figure 3. Polarizing signals promoting T cell differentiation into specific subsets 
with their signature transcription factors and cytokines. 
 
Follicular T helper cells 
It had been known for a long time that high quality B cell responses required 
T cell help. In 1985 Lanzavecchia directly showed that T cells can only solicit 
B cell help and support proliferation when they interact in an antigen specific 
and MHCII dependent manner (161). Initial findings identified the chemokine 
receptor CXCR5, originally known as Burkitt´s lymphoma receptor 1, to be 
expressed on memory T cells in blood (162). Soon after, when its ligand 
CXCL13 was shown be produced in B cell follicles (163) and that T cells 
upregulated CXCR5 in response to activation and responded to 
chemoattractant cues mediated by CXCL13 (164), the expression of CXCR5 
on tonsillar T cells was identified as a bona-fide marker for follicular homing 
T (Tfh) cells with the ability to provide B cell help  (165, 166). Gene expression 
analysis showed that Tfh cells, identified by CXCR5 and CD57 expression, 
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were transcriptionally different from Th1 and Th2 cells (167, 168). Later 
findings showed that Tfh develop independently from other T effector cell 
subsets (169) which strongly implied that Tfh constituted a novel T cell subset. 
A year later, a series of seminal papers identified the transcriptional suppressor 
Bcl6 as the master regulator of the Tfh subset (170-172). These studies 
solidified that Tfh cells constitute a separate subset by showing that loss of 
Bcl6 prevented Tfh cell generation while overexpression of Bcl6 forced Tfh 
subset commitment, and consequentially blocked T effector differentiation. 
As Tfh cells continued to be studied in great detail, it became increasingly 
evident that the development of Tfh is more multifaceted and refined compared 
to that of effector T cells. In contrast to T effector cell differentiation, which 
can be described as an event guided by one APC providing a polarizing set of 
signals during initial T cell activation, the differentiation of Tfh cells is best 
considered a multi-stage process in which not only the correct ligands and 
cytokines are needed but also where the timing is of utmost importance. 
Polarizing signals provided at the wrong time may have detrimental effect on 
Tfh differentiation. The fact that all T effector cell linages can be generated in 
vitro by following established protocols while to date, no such protocol exists 
for the successful generation of functional Tfh cells also provides a testament 
to the complexity of Tfh differentiation. To fully appreciate the intricacy of 
Tfh cell differentiation, a more in-depth discussion is warranted. 
The first stage of the multi-step process is the interaction with an APC that 
presents the cognate antigen and co-stimulatory ligands and cytokines. This 
initial interaction leads to an early commitment to Tfh cell or T effector cell 
differentiation marked by acquisition of Bcl6 or its antagonist Blimp-1 (170-
172), respectively. Exactly what signal(s) that determines the choice between 
Bcl6 and Blimp1 is not fully understood but early findings showed that the 
affinity of the TCR influenced T cell differentiation as higher TCR affinity 
correlated with preferential Tfh differentiation (173). However, later findings 
showed Tfh cells, in contrast to T effector cells, require continuous TCR 
stimuli and that antigen dose and sustained availability also influence T cell 
differentiation (174-176). At the moment, TCR:pMHCII dwell-time, the half-
life of productive TCR-pMHCII interaction,  is generally considered the best 
TCR-based predictor of cell-fate preference (177). 
The first co-stimulatory signal received by the T cells is mediated by CD28 
interaction with CD80 or CD86 on the APC which provides necessary co-
stimulation and leads to IL-2 production (178). Although IL-2 is important in 
the early stages of T cell proliferation, IL-2 stimulation and subsequent STAT5 
signalling quickly impairs Tfh cell differentiation (179-181). To counteract 
 22 
these negative signals, T cells committed to Tfh differentiation actively shield 
themselves from IL-2 signalling by several mechanisms. First, expressing 
lower levels of CD25 (IL2Ra), the high affinity receptor for IL-2,  compared 
to T effector cells is a hallmark of early Tfh differentiation as demonstrated by 
Crotty and colleagues (182, 183). Secondly, T cells that commit to Tfh 
differentiation reposition themselves to the T-B border and interfollicular 
areas. This occurs in response to chemotactic cues by EBI2 and CXCR5 where 
Tfh cells interact with DCs expressing high levels of CD25 that do not lead to 
downstream signalling, thus effectively sequestering IL-2 (184). Finally, Tfh 
cells are commonly characterized by their high expression of CXCR5 and 
programmed cell death protein 1 (PD-1) (185). PD-1 signalling efficiently 
supresses CD28 mediated IL-2 expression (186, 187), thus  preventing 
autocrine IL-2 signalling. 
OX40 was one of the first co-stimulatory molecules to be assigned a role in 
Tfh differentiation. OX40 stimulation was shown to promote IL-4 and CXCR5 
expression while supressing IFNg production induced by IL-12 in vitro (188). 
CD4+ T cell proliferation is also reduced in the absence of OX40 stimuli (189). 
Indeed, forced expression of OX40L on DCs boosts follicular homing (190) 
and in vivo administration of agonistic OX40L-hIgG1 in CD40-/- mice rescued 
follicular homing of CD4+ T cells (191). However, early OX40 stimuli during 
LCMV infection divert T cells from Tfh differentiation to T effector 
differentiation by upregulating Blimp-1 (192).  In addition, humans deficient 
in OX40 have normal antibody titres (193). These later findings would suggest 
that OX40 rather plays a context dependent, and perhaps redundant, role in 
dictating Tfh generation or function. 
Perhaps one of the most important Tfh promoting co-stimulatory signal by the 
APC at this point is ICOSL that binds ICOS on the T cell. ICOS and CD28 
belong to the same receptor family but unlike CD28, ICOS signalling does not 
lead to IL-2 production due to difference in a single amino-acid in the 
cytoplasmic tail (194, 195). CD28 is also expressed on resting naïve T cells 
while ICOS is upregulated following TCR signalling under the governance of 
the transcription factor Foxp1 (196). ICOS signalling promotes Tfh 
differentiation in a multitude of different manners. For instance, it potently 
induces expression of the master regulator Bcl6 (182) as well as protecting 
Bcl6 from ubiquitin-dependent protosomal degradation via PI3K mediated 
osteopontin translocation (197). Furthermore, ICOS signalling directly blocks 
the activity of two transcription factors, Klf2 and FOXO1, both acting to 
supress Tfh cell differentiation (198-200). Moreover, ICOS signalling is 
important for induction of the canonical Tfh cytokines IL-4  (201-203) and IL-
21 (204). While the expression of IL-21 is driven by c-Maf in Tfh cells as well 
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as Th17 cells (204, 205) it is still not clear how the Il-4 locus is operated in Tfh 
cells. Primarily, the transcription factor BATF have been assigned a role in 
governing IL-4 expression in Tfh cells (206, 207) and more recently, Notch 
dependent activation of the transcription factor RBP-J was identified as an 
important regulator of IL-4 expression Tfh cells but not Th2 cells (208).  
Recently, the Wnt-signaling induced transcription factor Achaete-scute 
homologue 2 (Ascl2) was found to potently induce CXCR5 expression when 
expression was forced in vitro, independently of Bcl6 expression (209). Ascl2 
overexpression in vivo caused an increased proportion of CXCR5 expressing 
CD4+ T cells at day 2 p.i.  but did not lead to increased CXCR5+ Bcl6+ Tfh cell 
numbers at day 6 p.i. when GCs are established, suggesting that Ascl2 is 
involved in early Tfh differentiation (209). In addition to Ascl2, Wnt signaling 
also activates the transcription factors TCF-1 and LEF-1 which have been 
reported to  early Tfh differentiation by regulating expression of Bcl6 and 
Blimp-1 (210-212) as well as a number of other genes associated with Tfh 
effector function (211). While conditional deletion of Tcf7 (encoding TCF-1) 
and Lef1 negatively impacts Tfh differentiation, Tfh differentiation in Tcf7 
deficient cells can at least be rescued by Bcl6 overexpression (210). 
Several soluble mediators, or cytokines, have been implicated in Tfh 
differentiation (213). IL-6 is perhaps the best described as it was shown to 
induce expression of the Tfh associated cytokine IL-21 (169, 214), which then 
can self-sustain IL-21 expression through IL21R signalling. The necessity of 
IL-6 or IL-21 for the successful generation of Tfh cells is questionable as 
several studies have shown that neither cytokine is an absolute requirement for 
Tfh differentiation and germinal center (GC) formation (214-217). Necessary 
or not, the effects of IL-6 and IL-21 deficiency are more profound when both 
cytokines are lacking, suggesting either overlapping or synergistic roles (214, 
216).  
The last important factor that have been implicated in the first stage of Tfh 
differentiation is the question of which cells that provide the stimulatory 
signals discussed above and where this interaction takes place. Under normal 
circumstances, cDCs have been attributed the role of the initiating APC as 
antigen presentation restricted to cDCs is sufficient to promote early Tfh 
differentiation (218). More recent studies have identified LN resident cDC2 
(CD4-expressing) (184) as well as migrating  cDC2 (219) to be important for 
Tfh differentiation.  Both sentinel and migratory cDC2 localize near the T-B 
border and the interfollicular area of the LN (184, 219), a niche where long-
lasting T-B interactions occur and the Tfh fate appears to be sealed (220). The 
cDC2s also express higher levels of ICOSL and CD25 than cDC1 where the 
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latter receptor permits quenching of IL-2 signalling in T cells, (184, 219). At 
least for the migratory cDC2, the position to this microenvironment is likely 
guided by higher expression levels of CXCR5, EBI2 in combination with 
reduced levels of CCR7 (219).  Upon activation, T cells poised to become Tfh 
cells downregulate PSGL1 and CCR7 (185, 217), which anchors T cells in the 
T cell zone,  and upregulate CXCR5 and EBI2 which consequently leads to 
homing to the T-B border and interfollicular area (164, 184, 185, 221). 
Although DCs are able to position themselves in the correct microenvironment 
and provide all the required signals for Tfh differentiation, they are not critical 
for Tfh differentiation and do not provide any unique signals necessary for Tfh 
differentiation. This is supported by the findings that Tfh cell develop in mice 
in which MHCII presentation is restricted to B cells during LCMV infection, 
albeit at reduced numbers, (222) as well is in mice where cDCs are transiently 
depleted as long as antigen is not limiting (223).  
At this point during Tfh differentiation, Bcl6 is established as the master 
transcriptional regulator and T cells have positioned themselves in the T-B 
border and interfollicular area where a cognate interaction with B cells initiates 
the second phase of Tfh differentiation (220). The relationship between T and 
B cells is of symbiotic nature as disruption of T-B interactions or depletion of 
one cell type leads to a reciprocal loss of the other during their concomitant 
differentiation towards GC cells (170, 185, 224). Even though CD40 
expression on non-B cell APCs is sufficient for T cells to migrate to the T-B 
border (191), CD40-CD40L interactions between T and B cells become crucial 
at this stage during development as CD40-/- B cells cannot support Tfh 
differentiation (225). For T cells to migrate further into the B cell follicle 
ICOS-ICOSL interaction between T and B cells, not necessarily in a cognate 
manner, have been shown to be of importance (226). This interaction 
potentially increases the contact duration and promote CD40 expression on B 
cells thereby creating a positive feedback loop (227).  
The signalling lymphocytic activation molecule family (SLAMF), consisting 
of seven family members, four of which are expressed on CD4+ T cells, bind 
in a homotypic manner to SLAMFs expressed on B cells. This family of 
molecules have been reported to be important at the stage of T-B interactions 
as in mice lacking CD84 (SLAMF5) the longevity of T-B interactions was 
compromised between T and B cells (228). This is also the case in mice lacking 
SLAM-associated protein (SAP). SAP functions as an adaptor protein to 
enhance SLAMF signalling, and T cells deficient in SAP show unaltered 
interaction with DC but fail to form stable conjugates with B cells (229). T 
cells deficient in SLAM (SLAMF1) also develop into Tfh cells but show a 
marked reduction in IL-4 production (230). Deletion of Ly108 (SLAMF6) in 
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SAP-/- mice restores the GC responses in these mice due to inhibitory signals 
mediated by tyrosine motifs in the cytosolic domain of Ly108, that SAP 
efficiently quench under normal conditions (231). Interestingly, while deletion 
of SAP negates Tfh differentiation at the stage of T-B interaction it was 
recently shown that GC responses were intact in mice with a complete deletion 
of the SLAM family (232). This suggests that the different members of the 
SLAM family may both positively and negatively regulate Tfh differentiation 
while not deliver any critical signals by themselves. 
The final phase of Tfh cell development is completed in the GC where Tfh 
cells, often termed GC Tfh cells at this stage, exert their effector functions. 
This is done by secreting cytokines, providing cognate co-stimulatory ligands 
to GC B cells that successfully acquired antigens, thereby selecting for B cells 
with the highest affinity. While several T cell derived cytokines can influence 
class-switching in B cells in a tailor-fitted manner to yield appropriate effector 
functions to the elicited immune response, IL-4 and IL-21 are the two 
cytokines associated with all GC responses. At first, IL-21 was thought to be 
critical to support maintained GC Tfh function through autocrine signaling 
(169). However, later studies contradicts this as both IL-21 and IL-21R 
deficient animals are capable of generating functional GC Tfh cells and defects 
are largely confined to the B cell compartment (233, 234). As stated earlier, 
IL-4 is the canonical cytokine secreted by the Th2 subset and was originally 
identified as a B cell stimulating cytokine (235). More recent studies using a 
murine model system in which active secretion of IL-4 can be detected by 
surface expression of human CD2 (236) revealed that IL-4 secreted in LNs is 
restricted to Tfh cells (203, 224, 237) and IL-4 / IL-13 co-secreting cells are 
largely confined to peripheral effector tissues (238). A study using fluorescent 
intravital imaging showed that prolonged cognate T-B interactions in the GCs 
sparked intracellular Ca2+ release which corresponded with IL-4 and IL-21 
production (239). This highlights the importance of continuous cognate 
interactions between T-B cells to maintain GC Tfh effector functions. 
Weinstein et al used a dual reporter system for IL-4 and IL-21 production and 
showed that there is a differential spatial distribution of IL-4 and IL-21 
producing cells within the GC (240). IL-21 producing cells locate in closer 
proximity to the dark zone than their IL-4 producing counterparts, which in 
turn express higher levels of CD40L. The finding that IL-4 producing GC Tfh 
cells express higher levels of CD40L is an interesting observation, considering 
that IL-4 and CD40 signalling in B cells synergistically induce an increased 
expression of activation-induced deaminase in B cells (241). In addition to IL-
4 and IL-21 production, novel studies have revealed GC Tfh cells to be a source 
of both dopamine and IL-9 (242, 243). Functionally, dopamine signalling in B 
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cells leads to transportation of ICOSL to the B cell surface (242) and IL-9 was 
shown to promote generation of B cell memory (243). 
Regulatory T cells  
The first observation of a CD4+ T cell subset with immunosuppressive 
functions was made by Sakaguchi et al who identified CD4+CD25+ T cells as 
a subset capable of supporting self-tolerance (244). The findings that 
deficiency of the transcription factor FoxP3 caused fatal immunopathology and 
loss of CD4+CD25+ T cells established regulatory T cells (Tregs) as a separate 
T cell subset (245). Tregs supress target cells by three distinct modes of 
actions; first, they can mediate suppression by cell-cell interaction by 
providing the suppressive ligands CTLA-4 (246) and LAG-3 (247). Second, 
secretion of cytokines, most commonly, IL-10 is strongly associated with 
immunosuppression (248) and finally, expression of the ectoenzymes CD39 
and CD73 can convert pro-inflammatory ATP into adenosine to yield an 
immunosuppressive niche (249). An early study identified Tregs capable of 
regulating GC response in human tonsils (250). Based upon this study, a subset 
of Tregs termed T follicular regulatory cells (Tfr) residing in the GCs and 
exhibiting the Tfh-associated CXCR5+PD-1+Bcl-6+ phenotype in addition to 
FoxP3 expression was identified by three independent groups in 2011 (251-
253). Initially, Tfr cells were thought to be reactive against self-antigens as a 
way to prevent auto-immunity until a recent study demonstrated that Tfr cells 
with the same reactivity can be generated against an antigen recognized either 
as self or foreign (254). This suggests that Tfr cells may also regulate the 
magnitude of non-self GC responses. CTLA-4 mediated suppression has been 
reported to regulate GC Tfh function (255, 256) but the exact mode of action 
of Tfr mediated suppression of the GC responses remains to be fully 
elucidated. 
Homing and recruitment 
Early work by Eugene Butchers´ lab demonstrated that CD4+ T cells prone to 
follicular or tissue homing developed in parallel (257) and that the site of 
priming consequently lead to expression of tissue-specific homing receptor 
associated with skin or gut trafficking shortly after activation in skin or gut 
draining LNs, respectively (258) (Figure 4).  
Follicular homing 
While Tfh cells rely on downregulation of CCR7 and concomitant 
upregulation of CXCR5 and EBI2 to reach the T-B border and interfollicular 
area as discussed earlier, GC Tfh cells rely on slightly different mechanisms to 
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migrate into the follicle and position themselves in the GC. First, in contrast to 
developing Tfh cells, GC Tfh cells have downregulated EBI2 (259) just like B 
cells that have received T cell help (260, 261), thus localizing in the GC in a 
oxysterol independent manner. The GC can be subdivided into two 
anatomically distinct areas, namely the dark zone (DZ) where B cells 
proliferate and undergo somatic hypermutation (SHM) and light zone (LZ), in 
which B cells receive T cell help from Tfh cells. This compartmentalization is 
governed by the chemoattractants CXCL13 produced by follicular dendritic 
cells (FDCs) in the LZ (262) and CXCL12, also known as stromal cell-derived 
factor 1 (SDF-1), produced by CXCL12-expressing reticular cells (CRCs) in 
the DZ (263, 264). Tfh cells are largely confined to the light zone due to their 
high expression of CXCR5 attracting them to the CXCL13 rich area of the dark 
zone. Interestingly, besides being a prime source of CXCL13, FDCs were 
shown to induce CXCR4 expression on CD4+ T cells when co-cultured in vitro 
and GC Tfh cells showed higher levels of CXCR4 compared to non-GC T cells 
in vivo (265). However, despite their expression of CXCR4, GC Tfh cells are 
essentially nonresponsive to CXCL12 due to FDC mediated upregulation of 
RGS13 and RGS16 (266), two proteins capable of regulating G protein 
receptor signalling. This highlights the crucial role of FDCs in orchestrating T 
cell positioning within the GC. While the GC is an immobile anatomical 
structure, GC Tfh cells readily shuttle between existing GCs within a LN (267). 
This could possibly be a mechanism to increase diversity in potential T cell 
help although exactly what mechanisms that operate this dynamic inter-GC 
migration are still not known.  
Peripheral homing 
The first gut homing-associated marker observed on lymphocytes was the 
a4b7 integrin, capable of binding MAdCAM-1 present on post-capillary 
endothelial venules in the small intestine (22, 23). MLNs draining the gut 
potently imprint a4b7 expression in comparison to skin draining LNs (258) 
and during the early stages of CD4+ T cell priming in MLNs expression of 
a4b7 and CXCR5 is mutually exclusive (268). Co-culture experiments with T 
cells and cDCs showed that cDCs from MLNs and also PPs efficiently induce 
T cell expression of a4b7 as well as CCR9 (269-271), a chemokine receptor 
associated with small intestinal homing (272). A study by Iwata et al 
demonstrated that the vitamin A metabolite retinoic acid (RA) strongly 
induced both a4b7 and CCR9 expression on T cells activated in vitro under 
non-polarizing conditions (273). Furthermore, the same study showed that 
cDCs in gut-draining lymphoid organs were capable of metabolizing vitamin 
A into RA. Consequently vitamin A deficient diet lead to depletion of lamina 
propria T cells (273). While CD103+ and not CD103- cDCs in MLN are the 
only cDC subset capable of generating a4b7+ CCR9+ gut-homing CD8+ T cells 
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(37), this distinction does not fully apply to CD4+ as CD103- cDCs from MLN 
can induce a4b7 but not CCR9 expression (274). The expression of CCR9 
allows CD4+ T cells to interact with CCL25 produced by epithelial cells in the 
SI LP (38) but also presented on the endothelial cells in post-capillary venules 
to support transmigration over the endothelium (39, 40). Lastly, the relative 
importance of CCR9 contribution to SI LP homing appears more profound 
among CD8+ T cells as in competitive transfer experiments CCR9-deficient 
cells were prominently outcompeted by their wild-type counterparts following 
immunization (41). In contrast CCR9-deficient CD4+ T cells only show a 
modest reduction in SI LP homing compared to wild type CD4+ T cells (42). 
Figure 4. General overview of T cell movement after activation in MLNs 
Memory 
The findings that the subset defining transcription factors actively repress other 
subset associated transcription factors, thereby competing for dominance of the 
transcriptional landscape, introduced the idea that T cells commit to perform 
one function at a time. However, strong environmental cues can reprogram 
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effector T cells into other T helper subsets (Reviewed in (275, 276)). This 
plasticity of T cells to re-differentiate into other T helper subsets is perhaps 
best conserved in Tfh cells as they resourcefully re-differentiate into effector 
T cells after transfer into naïve hosts and subsequent challenge in both Th1 and 
Th2 skewing systems (224, 277-279). 
The ability of antigen experienced T cells to survive over extended periods of 
time, proliferate, re-differentiate and quickly respond upon antigen re-
challenge is one of the most important features of the adaptive immune system, 
namely immunological memory. Traditionally, T cell memory has been 
divided into two compartments, T central memory cells (Tcm) and T effector 
memory cells (Tem) based on their differential localization. Tem, defined as 
CD44+CD62L-CCR7- cells, reside in peripheral tissue, poised to swiftly react 
to re-infection whereas Tcm, which maintain CCR7 and CD62L expression, 
are harboured in secondary lymphoid organs and preferentially proliferate to 
generate more effector cells (280). The generation of Tem cells was shown to 
be independent of Bcl6 while the generation of Tcm cells requires Bcl6 
expression (281), suggesting that Tcm may arise from Tfh cells. 
Indeed, studies have identified that memory GC Tfh cells have the capacity to 
efficiently become GC Tfh cells upon antigen re-challenge while non-CXCR5 
expressing T cells poorly reconstitute the GC Tfh pool (277, 278, 282). When 
Tfh cells enter the resting memory phase the expression of both Bcl6 and ICOS 
are reduced while the levels of CCR7 and CD62L are upregulated (283). Thus, 
memory Tfh cells will adopt a phenotype more akin to the classical Tcm 
phenotype. Over the course of the immune response memory T cells 
disseminate into non-draining LNs and aptly respond to antigenic stimuli 
(284). Interestingly, it was recently shown that the memory pool in non-
reactive LNs preferentially consists of T cells with lower TCR affinity (285). 
Moreover, memory cells in the reactive LN were spatially localized to the outer 
follicle or in close proximity to the subcapsular sinus whereas circulating Tfh 
cells resided in the T cell zone (285, 286). In summary, T cell memory is 
maintained by several distinct memory cells that serve different purposes, 
where Tfh cells are important for re-initiation of the GC response in both 
previously exposed LNs as well as non-draining LNs. 
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B cells 
The second arm of the adaptive immune system is composed of B cells that 
can develop into plasma cells capable of producing immunoglobulins (Ig), i.e. 
antibodies, to confer humoral immunity. Antibodies are heterodimeric 
glycoproteins consisting of two light chains and two heavy chains paired to 
each other capable of binding antigens with high specificity. Antibodies 
mediate a wide variety of effector functions ranging from toxin neutralization 
to complement activation or opsonization. In this chapter, I will briefly cover 
the B cells development, how high-affinity antibodies are generated in T-
dependent response in the GC and the outcomes of the GC reaction. 
Development and maturation 
B cells develop in the BM from progenitor (pro)-B cells committed to the B 
cell lineage. In a manner similar to T cells Pro-B cells undergo a series of error 
prone random gene rearrangement of the Ig heavy chain locus to generate a 
uniquely recombined set of V-D-J segments guided by RAG1/2 and TdT 
enzymes (287, 288). The successful recombination of a V segment to DJ 
segments yields a functional heavy chain paired with a surrogate light chain, 
called pre-B-cell receptor, which induces allelic exclusion of the IgH locus to 
prevent further rearrangements of the heavy chain (289). This subsequently 
allows for V-J recombination of the light chain locus to be initiated. Once light 
chain recombination has resulted in a light chain capable of pairing to the IgM 
isotype heavy chain the developing B cell starts expressing the dimeric 
immunoglobulin on the cell surface which serves as the BCR. Before leaving 
the BM, the possible autoreactivity of the BCR is controlled. Self-antigens are 
presented in the BM and immature B cells carrying a self-reactive BCR are 
eliminated or undergo receptor editing to replace the light chain (290). 
Immature B cells then egress from the BM to the spleen where they receive 
survival signals and complete their early development by differentiating into 
naïve follicular or marginal zone B cells (291, 292). 
T dependent B cell responses 
Follicular B cells acquire antigens by the antigen binding regions of the BCR 
that, in contrast to the TCR, which recognizes MHC-peptide complexes, 
directly interact with the native form of the antigen. Soluble antigen arriving 
to the LN can either directly diffuse into the follicle through pores or be 
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retrieved by subcapsular sinus-lining macrophages which transfers the antigen 
to FDCs (293-295). B cells acquire the antigen from either of these cells by 
binding of antigen to the BCR. This leads to B cell activation by inducing 
intracellular activation signals and internalization of the antigen-bound BCR 
for degradation in endocytic vesicles. If the antigen contains a protein 
component this leads to antigen presentation of antigen-derived peptides on 
MHCII molecules (296). Following activation, B cells migrate to the T-B 
border in a CCR7-dependent manner (297) aided by EBI2 towards the 
interfollicular region (260, 298). This interfollicular region-aimed movement 
occurs in parallel with that of CXCR5 expressing activated Tfh cells which 
facilitates the encounter of antigen specific T cells and antigen presenting B 
cells (220). 
The phase following initial T-B interactions, referred to as the extrafollicular 
response, involves clonal expansion and fate commitment to differentiate into 
extrafollicular plasma cells (PC), IgM+ memory B cells or proceed onto the GC 
B cell differentiation pathway. Extrafollicular PCs are short-lived cells with an 
estimated life span of 3 days (299) that provide early protection by producing 
low-affinity antibodies (300). The magnitude and clonal selection of the 
extrafollicular response is determined by the affinity of the reactive BCRs and 
antigen dose, which corresponds to expansion of PCs and size of the 
extrafollicular foci (301, 302). T cells also play a role in the differentiation of 
extrafollicular plasma cells as T cells deficient for Bcl6 (303) or CD40L (304) 
show significantly impaired extrafollicular responses during T dependent 
responses. Presumably, T cells provide signals, possibly via IL-21 (305), that 
regulate Blimp-1 expression to promote PC differentiation of B cells (306).  
In response to stimuli from T cells, B cells start to switch isotype expression 
from IgM and IgD to IgA, IgE or IgG constant regions. This process known as 
class-switch recombination (CSR) is a means to adequately adapt the antibody 
mediated effector response to the invading pathogen. This process is initiated 
by cytokine induced expression of germline transcripts which guides the 
enzyme activation-induced cytidine deaminase (AID) to switch-regions (307). 
AID was first identified in cells undergoing CSR in vitro and was shown to be 
able to convert cytosine into uracil by deamination (6, 308). This ultimately 
leads to single strand breaks and C-G to A-T transition after DNA repair. 
Switch regions have high density of C-G base pairing, making them a prime 
target for AID activity. The introduction of multiple strand breaks in the switch 
region eventually causes double strand break. Such breaks at Cµ and Cg switch 
regions allow non-homologous end-joining to replace Cµ with Cg resulting in 
isotype switch from IgM to IgG.  
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Similar to GC Tfh cells, B cells undergoing GC B cell differentiation must 
suppress Blimp-1 expression and express high levels of Bcl6, which actively 
represses Blimp-1 expression (309, 310). In addition to repressing Blimp-1 and 
PC differentiation Bcl6 also suppresses the anti-apoptotic protein Bcl-2. Hence 
GC B cells are prone to apoptosis and require continuous survival signals from 
T cells. Expression of Bcl6 in B cells is, at least partially, induced by the Tfh 
associated cytokines IL-4 and IL-21 (311-313). Consequently, GC responses 
in mice deficient for both IL-4 and IL-21R are severely impaired (313). 
However, IL-4 and IL-21 play a dual role in this aspect of B cell survival, as 
they also stimulate B cell proliferation and survival (233, 235, 314), although 
neither signal is individually critical for GC B cell survival. A non-redundant 
signal in GC B cell survival is CD40 stimulation which is provided by CD40L 
on T cells. Cell cultures of GC B cells stimulated with a-Ig, which rapidly 
undergo apoptosis due to the pro-apoptotic state induced by Bcl6, can be 
rescued from apoptosis if agonistic CD40 antibodies are present (315). In vivo, 
the necessity of CD40L-CD40 interactions have been shown to be important 
during both early GC B development and late GC B cell survival. Mice treated 
with blocking CD40L antibodies during the first 3 days of an immune response 
failed to generate functional GCs (316, 317) and treatment at later stages 
rapidly abolished already formed GCs (316, 318). Furthermore, CD40 
signalling in B cells is important for expression of AID (241), the enzyme 
driving CSR and somatic hypermutation (SHM). Hence absence of CD40 
signalling leads to loss of class-switched antibodies in T dependent but not T 
independent responses (304, 317, 319). At this stage B cells that have been 
selected to become GC B cells start to downregulate EBI2 (260, 261) and 
migrate into the follicle in responses to chemotactic cues by CXCL13 produced 
by FDCs (262) and CRC derived CXCL12 (263, 264). The aggregation of B 
cells centred around FDCs and CRCs results in the formation of the GC and 
its polarization into two distinct compartments with differential functions. 
Germinal center process 
The germinal center (GC) is the location where B cells undergo rapid 
proliferation and SHM in an attempt to increase the antigen affinity of the 
BCR. The GC reaction is perhaps best described as a microcosm where 
evolution takes place at the single cell level by SHM and survival is regulated 
in a Darwinistic fashion, in which fitness is defined by BCR affinity. These 
processes take place separately in the two distinctive compartments of the 
germinal center, namely the dark zone (DZ) and the light zone (LZ). In this 
section, the processes taking place in these compartments will be dissected 
(Figure 5). 
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The dark zone 
The positioning of GC B cells into the DZ is dependent on CXCR4 mediated 
chemotaxis towards the gradient of CXCL12 produced by stromal cells in the 
DZ (320). In the DZ, GC B cells, called centroblasts at this stage, rapidly 
proliferate to generate a large pool of centroblasts. Newly generated 
centroblasts express AID that introduces nucleotide changes in the V region of 
Ig genes, which contain the antigen binding complementarity determining 
regions. Each and every progeny cell from the centroblasts acquires a unique 
set of somatic mutations resulting in a great spread of BCR affinities within 
the pool. Given that AID is involved in CSR, it begs the question whether CSR 
also occurs in AID expressing centroblasts in the DZ. While GC B cells can 
express low amounts of germline transcripts (321), expression levels of 
germline transcripts peaks early during the immune response. Antigen specific 
class-switched B cells can be found already day 2 post-immunization which 
suggests that CSR preferentially occurs prior to GC entry (322, 323). Once 
SHM is completed centroblasts internalize CXCR4 and start migrating to the 
LZ. 
The light zone 
If the DZ is considered to be where the evolution of GC B cells transpires, the 
LZ is where their fitness is tested. In the LZ antigen can be retained for 
extended periods of time in immune complexes bound to complement receptor 
2 present on the surface of FDCs (324). GC B cells in the LZ, commonly 
referred to as centrocytes, are able to capture antigen present on the FDCs via 
the BCR which triggers internalization of the antigen bound BCR. Centrocytes 
compete for antigen binding of the immune complexes and the capacity of 
centrocytes to acquire antigen is directly dependent on the affinity of their BCR 
(325). This competition of antigen binding is indeed “a matter of life and 
death” as antigen uptake directly correlates to peptide presentation and 
consequently T cell help from GC Tfh cells that provide survival signals. Due 
to their Bcl6 mediated pro-apoptotic nature, centrocytes that fail to compete 
for antigen are deprived of survival signals and undergo apoptosis.  
Centrocytes expressing higher affinity BCR that successfully acquired antigen 
and received T cell help can differentiate into antibody producing PCs, become 
memory B cells or re-enter the DZ to clonally expand and be subjected to SHM 
once again. Centrocytes that opt to re-enter the DZ undergo additional rounds 
of competition between centrocytes that have accumulated even more 
mutations during SHM thus potentially increasing their BCR affinity even 
further. Antibodies produced by GC derived PCs can replace antibodies bound 
to immune complexes thereby increasing the minimum affinity requirements 
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of centrocytes to acquire antigen (326). This mechanism is suggested to 
guarantee the generation of antibodies with higher affinity. 
The critical role of T cells in GC B cell selection has been elegantly elucidated 
by Victora et al  by using targeted antigen delivery to GC B cells using a 
aDEC205 antibody conjugated to Ovalbumin (OVA) in mice that received 
adoptive transfer of DEC205+/+ or DEC205-/- B cells (89). This model bypasses 
affinity based BCR mediated uptake of antigen as DEC205+/+ B cells will 
acquire and present more pMHCII compared to DEC205-/- B cells and vastly 
outcompete DEC205-/- B cells in receiving T cell help (89). Furthermore, when 
aDEC205-OVA antibodies are administered to wild-type (DEC205+/+) mice 
causing all B cells to present equal amounts of pMHCII regardless of BCR 
affinity, there was a profound effect on affinity maturation (89). As discussed 
earlier, several T cell mediated signals have been reported to be critical for GC 
maintenance. ICOS-ICOSL interactions was early identified to be important 
for GC maintenance and IgG class-switch as ICOS signalling induces CD40L 
and IL-4 expression in T cells (201, 202). However, ICOSL delivered in a 
bystander fashion is sufficient for normal GC induction with only a modest 
reduction in affinity selection (227). In addition, administration of agonistic 
aCD40 antibodies rescues class-switching in ICOS-/- mice (327), indicating 
that the effects of ICOS-ICOSL is largely T cell dependent. A recent study 
observed that BCR signalling induced Bcl6 degradation at the protein level 
(328). However, IL-4 and IL-21 signalling via STAT3 and STAT6, 
respectively, protected Bcl6 from degradation. This identifies a novel role for 
IL-4 and IL-21 in the safeguarding of GC B cells. These experiments illustrate 
how BCR affinity and T cell help in concert ensures cyclic affinity-based 
selection in the GC. 
Germinal center output 
The GC reaction results in generation of long-lived antibody producing PCs 
that can survive for extended periods of time in the absence of antigenic 
stimuli. It also generates a pool of memory B cells that swiftly respond upon 
secondary infections and differentiate into PCs or re-enter the GC reaction. The 
longevity of PCs in combination with the capacity of memory cells to respond 
to secondary challenges together constitutes the foundation of serological 
immunity. In contrast to extrafollicular PCs that have few mutations and 
relatively low affinity, PCs originating from the GC reaction are highly 
mutated and, due to the selection processes in the GC, secrete antibodies with 
significantly higher affinity than the antibodies generated by their 
extrafollicular counterparts. PCs with a history of GC reaction also produce 
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class-switched antibodies guided by cytokines and therefore have their 
function tailor-fitted to the needed immune response. 
Selection into the PC compartment is directed by Blimp-1 (306, 329). The 
exact mechanism that promotes Blimp-1 induction is not entirely known. IL-
21 has been shown to induce both Blimp-1 and Bcl6 expression in B cells 
(305), suggesting that IL-21 signalling may act as a rheostat in GC B cell 
decisions. Indeed, several studies have reported impaired PCs formation, CSR 
and SHM in the absence of IL-21 signalling (217, 233, 314), coupled to an 
accelerated generation of memory B cells with lower mutation frequency 
(233). However, it should be noted that these studies have largely been 
conducted with IL-21-/- and IL-21R-/- animals, making discrimination between 
T and B cell intrinsic effects difficult. A study by McGuire et al used adoptive 
transfer of transgenic IL-21R+/+ or IL-21R-/- CD4+ T cells into IL-21R sufficient 
and deficient hosts to dissect this (234). The authors found that IL-21R+/+ but 
not IL-21R-/- T cells could restore both GC B cell numbers and high affinity 
IgG during secondary responses. Several studies have observed that GC 
derived PCs have a greater frequency of mutations leading to higher affinity 
than GC B cells in two separate model systems in which the high affinity 
mutations are well described, indicating that BCR signaling strength also 
regulates PC differentiation (301, 330, 331). The mechanisms that dictate 
memory selection are less well understood. Memory B cells have lower affinity 
than PCs, suggesting that either strong BCR stimuli prevent memory cell 
generation by promoting PC differentiation or that memory cells are generated 
early during the GC reaction before acquiring high affinity mutations (330). 
Indeed, Weisel et al showed that CD80- PD-L2- memory B cells primarily arise 
at the early stages of the GC response whereas memory B cells that arise during 
the later stages of the GC reaction express CD80 and PD-L2 (332). This 
phenotypic distinction of memory B cells have been shown to be associated 
with differential functions. Upon rechallenge, CD80- PD-L2- memory B cell 
preferentially re-enter the GC while CD80+ PD-L2+ memory B cells 
predominantly become antibody producing cells (333). GC Tfh-produced IL-
9 was recently shown to induce cell cycle arrest in the S-phase followed by 
acquisition of memory phenotype in GC B cells (243). Conversely, IL-9 
blockade prevented memory formation indicating that GC Tfh cells may help 
govern memory B cell output. 
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Figure 5. The process and outcomes of the germinal center reaction 
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Aim 
The overall aim of this thesis was to investigate the role of different APCs, 
with a focus on DCs and B cells, in terms of T effector cell versus Tfh cell 
differentiation in the context of protein adjuvant immunization.  
Specific aims were: 
• To determine if cDCs send unique accessory signals 
required for the differentiation of Tfh cells 
• To identify genes in Th cells that are regulated by B cells 
early following immunization 
• To investigate if B cells play a role in the generation and 
output of peripheral T effector cells  
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Key methodologies 
Mice 
The complex nature of the immune system cannot in its entirety be faithfully 
replicated in vitro and is best studied in vivo. For this purpose, we have used 
mice as our model animal. This is due to the rapid reproduction cycle, many 
commercially available genetic models in addition to their immune system 
being relatively similar to that seen in humans. However, as mice are inbred 
over several generations to maintain the genetic identity they lack the diversity 
at individual level seen in the human population. Throughout this thesis we 
have used the C57BL6/J strain as our wild type (wt) control mouse and all 
transgenic and knock-out (KO) mice used are based on the C57BL6/J 
background. Transgenic mice are mice that carry a DNA insert from another 
source used as a means to give the cells in the mouse additional properties. 
Conversely, KO mice have a specific deletion of a gene. In this thesis we have 
exploited several transgenic and KO mice with specific phenotypes. For 
instance, the CD11c-DTR mice in Paper I express the diphtheria toxin (DTx) 
receptor, which is not naturally expressed in mice, under the control of the 
CD11c promotor (81). This allows for ablation of CD11c expressing cells by 
administration of DTx. Another mouse strain central to this thesis is the OT-II 
mice in which CD4+ T cells express a TCR transgene that specifically 
recognizes an OVA-derived peptide presented on MHCII. The OT-II mice 
strain is crossed onto a congenic mouse expressing the allelic variant CD45.1 
whereas C57BL6/J mice carry the CD45.2 variant. This discrete difference in 
CD45.1 alleles allows for tracking of CD45.1+ OT-II cells after being 
adoptively transferred into CD45.2+ congenic hosts.  For a summary of mice 
strains used in this thesis, see Table 1. 
Table 1 Mouse strains used in this thesis 
STRAIN PHENOTYPE 
CD11c-DTR Mice expressing diphtheria toxin receptor under control of the CD11c promotor 
MHCII-/- KO mice deficient for MHCII 
CD11c-DTR x MHCII-/- MHCII KO mice carrying the CD11c-DTR transgene 
µMT KO mice unable to generate B cells 
B1-8hi - GFP B cells express the transgenic high affinity anti-NP BCR 
CX3CR1-/GFP CX3CR1 KO mice with transgenic GFP replacing one of the two alleles 
OT-II CD4 T cells express a transgenic TCR specific for an OVA-derived peptide. CD45.1+ 
ICOS-/- OT-II ICOS KO mice with the OT-II transgene 
KN2xOT-II OT-II mice in which one IL-4 allele is replaced with hCD2 to track IL-4 secretion 
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Bone marrow chimeras 
Transplantation of BM into lethally irradiated hosts is a technique that can be 
used to transfer a phenotype from a donor mouse onto the hematopoietic 
compartment of the recipient mice. For instance, CD11c-DTR mice 
administered DTx will succumb after a few days due to loss of non-
hematopoietic CD11c expressing cells (81). Hence, in CD11c-DTR BM 
chimeric mice DTx can repeatedly be administered over extended periods of 
time without affecting the non-hematopoietic compartment since only the cells 
of the hematopoietic compartment reconstituted by CD11c-DTR bone marrow 
express the receptor. Moreover, the transferred BM can be composed of two 
different backgrounds to generate a hematopoietic compartment with mixed 
phenotypes. The mixed BM strategy has been exploited in all papers and in 
particular Paper II and Paper III in which we have reconstituted mice with 4:1 
ratio of µMT / C57BL6/J (Control) and µMT / MHCII-/- (MHCIIB-/-) to 
generate bone marrow chimeras with a mixed phenotype. In this case, 80% the 
hematopoietic compartment is of µMT origin which cannot support B cell 
development, effectively causing all B cells generated to be of either 20% 
C57BL6/J or MHCII-/- origin rendering B cells either capable of presenting 
antigens on MHCII molecules or not. This strategy was also employed in Paper 
I where 4:1 mixed bone marrow chimeras from CD11c-DTR/µMT and MHCII-
/- were used to generate mice in which B cells could not present antigens and 
cDCs were either deficient for MHCII or could be transiently depleted by DTx 
administration. 
Thoracic duct cannulation 
For collection of bona fide migrating T cells, we cannulated the thoracic duct 
and collected the efferent lymph containing thoracic duct lymphocytes (TDL) 
overnight. The thoracic duct is the largest lymphatic vessel and serves as a 
focal point for many efferent lymphatics vessels, including all of the intestinal 
draining LNs. This method has been used to collect migratory APCs in mice 
that have had their MLNs removed by mesenteric lymphadenectomy (50). In 
mice with intact MLNs, migratory cDCs do not exit the LN into the efferent 
lymph and the TDLs largely consists of recirculating T and B lymphocytes. 
Flow cytometry & fluorescence activated cell sorting 
The identification of immune cells is based on their expression of cell-type 
associated markers either present on the cell surface or intracellularly. In flow 
cytometry, target specific antibodies conjugated to fluorochromes that are 
excited by light, or laser, of a certain wave length and emit light of a higher 
wavelength upon excitation are used to label markers of interest. Each laser 
used can excite multiple fluorochromes with distinct emission spectra, 
allowing analysis of a multitude of targets simultaneously at a rate of over 
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15 000 cells per second. This combination of speed and possibility to analyze 
multiple targets at the same time makes flow cytometry the best method to 
perform multi-parameter characterization and analysis of cells within a diverse 
population like a lymphoid organ. 
By forcing the antibody labelled cell suspension through a vibrating nozzle 
under high pressure, a stream of small fluid droplets containing a single cell is 
formed. The stream of droplets subsequently passes through a series of lasers 
serving as excitation sources for different wavelengths. The emitted light is 
separated by a series of wavelength specific mirrors and filters into detectors 
and the emission spectra and signal strength for each antibody labelled target 
as well as the light scatter caused by the cell is analysed to determine the size 
and granularity of cells.  
An additional feature of flow cytometry is the ability to isolate individual cells 
or all cells defined by a desired phenotype in what is called fluorescence 
activated cell sorting (FACS). By applying a high voltage over two metal plates 
situated on opposing sides of the droplet stream it is possible to sort individual 
droplets containing cells of interest into tubes or cell culture plates. In this 
thesis we have sorted OT-II cells based on their phenotype into tubes 
containing lysis buffer to perform gene expression analysis. 
Gene expression 
To measure the expression of genes at the mRNA level we performed 
quantitative real-time PCR on sorted OT-II cells activated both in vivo and in 
vitro. After sorting into lysis buffer, we purified mRNA transcriptome by spin 
column purification for subsequently reverse transcription to generate a cDNA 
library of the transcriptome. Similar to traditional PCR, target specific primers 
allows for amplification of gene specific fragments. The amplified dsDNA 
product allows for the binding of a probe that becomes fluorescent when bound 
to dsDNA. Hence, the fluorescent signal will increase in a logarithmic manner 
with every amplification cycle. By comparing the fluorescent signal of the 
gene of interest with a house keeping gene, a highly and stably expressed gene, 
the relative levels of mRNA transcripts can be estimated. 
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Results & Discussion 
Paper I – The role of DCs in initiating CD4+ T cell responses 
The development of Tfh cells is dependent on several molecular interactions 
including ICOS-ICOSL engagement and cellular interactions with B cells to 
form functional GC residing Tfh cells (222, 334). DCs have long been 
considered to be necessary and sufficient for early Tfh induction as antigen 
presentation restricted to cDCs in both molecular models and adoptive transfer 
of antigen loaded cDCs is sufficient to initiate the Tfh differentiation program 
(218, 335). Early Tfh differentiation is marked by an upregulation of CXCR5 
and movement to the T-B border that occurs independently of expression of 
Bcl6 the bona-fide transcription factor of Tfh cells (277). B cell restricted 
antigen presentation is sufficient to induce functional Tfh cells during LCMV 
infection but not protein immunization (222), calling into question whether 
cDCs deliver unique signals necessary for Tfh differentiation provided in trans 
or if it is their potency in inducing T cell expansion that make them non-
redundant in conventional immunization regimens. To address if cDCs provide 
critical and non-redundant signals in Tfh development we studied Tfh 
generation in the absence of cDCs during initial T cell priming. To this end, 
we adoptively transferred congenic CD45.1+ OT-II cells that carry a transgenic 
TCR specific for OVA into CD45.2+ CD11c-DTR hosts. The cDC population 
in CD11c express a transgenic receptor for DTx allowing for transient 
depletion of cDCs that lasts for approximately 72h (81). After immunization 
with OVA and the dsRNA analogue polyI:C which stimulates TLR3, this 
model system allows for analysis of antigen specific CD4+ T cells, at selected 
time points, primed in the absence or presence of cDCs. 
T cell expansion in the absence of cDCs require higher antigen dosing  
Given their unparalleled ability to efficiently take up and present antigens, 
cDCs are considered to be the most potent APC in terms of inducing T cell 
responses. Ablation of cDCs have previously been reported to severely impair 
CD4+ T cell priming when antigen is administered at mucosal sites but not 
when high antigen dose is administered systemically (336). In initial 
experiments we immunized mice intraperitoneally (i.p.) with 300 µg OVA and 
100 µg polyI:C and observed a reduction in expansion of OT-II in cDC 
depleted mice (Figure 6A) accompanied with failure to downregulate CD62L 
and decreased expression of CXCR5, suggesting impaired CD4+ T cell 
activation. To distinguish between the antigen presentation and accessory 
functions of cDCs, we pursued by administering a 10-fold higher antigen dose 
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to allow antigen uptake and presentation by other, less proficient, APCs.   
 
In response to non-limiting antigen dose OT-II proliferation, Tfh 
differentiation and GC B cell generation was rescued, showing that other APCs 
can support the induction of T cells responses and that cDCs play a non-
redundant role in this aspect (Figure 6A and C). This is in line with a previous 
study that report a correlation between antigen dose, Tfh and GC B cell 
generation (318), albeit more pronounced in the absence of cDCs. 
Interestingly, OT-II cells primed in the absence of cDCs showed reduced 
amount of the Th1-associated cytokine IFNg (Figure 6B). Intracellular staining 
and mRNA expression levels for the Th1 and Tfh associated transcription 
factors T-Bet and Bcl6, respectively, confirmed that the Th1 but not Tfh 
program was compromised in cDC ablated mice. This indicates that cDCs may 
be more important for Th1 responses than Tfh differentiation. Functionally, 
the reduction of Th1 polarization had downstream implications of the B cell 
response as GC B cells preferentially expressed Tfh associated IgG1 and not 
Th1 associated IgG2c antibody isotypes in cDC depleted mice. Besides of the 
bias towards IgG1 isotype switching, GC responses were normal as cDC 
ablated animals showed normal affinity maturation and memory responses. 
Collectively, this shows that cDCs are redundant for Tfh cell differentiation 
but necessary for Th1 cell differentiation and their associated responses. 
Figure 6. High antigen dose by-passes the requirements for cDC in germinal 
center formation. (A-C) OT-II expansion (A), IFNg  production (B) and induction 
of GC B cells (C) d14 p.i. following indicated doses of OVA and DTx treatment. 
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The issues of antigen dosage and de novo generated cDCs 
One of the key questions that arose during this study concerned the antigen 
dosage. While another study have shown that antigen presentation restricted to 
B cells can promote Tfh induction, albeit inefficiently, during chronic viral 
infection (222), it is difficult to evaluate how a chronic infection translates into 
protein immunization in terms of antigen availability.  Certainly, 3 mg of OVA 
certainly can be considered as an extreme amount of antigen and we sought to 
address whether the induction of Tfh cells could be initiated by de novo 
generated cDCs that present lingering antigen. To test this, we first assessed 
when cDCs start to re-emerge in the spleen after DTx depletion and noted that 
the reconstitution of cDCs is first evident at 86h post depletion. By transferring 
OT-II cells at various time points in relation to immunization into wild type 
mice that had received 3 mg we found that OT-II cells need to be present at the 
time of immunization to be efficiently primed.  
Figure 7. Early Tfh differentiation is dependent on ICOS-ICOSL in cDC depleted 
animals. Competetive transfer experiment of wt and ICOS-/- OT-II cells d3 p.i. with or 
without DTx treatment in BMHCII-/- CD11c-DTR/B6 mice 
Since GC B cells eventually start to express the DTR transgene in CD11c-DTR 
mice, continuous administration of DTx will deplete GC B cells and 
consequently terminate the GC reaction (318). To circumvent this effect and 
further dissect which APCs were responsible for T cell priming in the absence 
of cDCs, we generated bone marrow chimeras in which cDCs are sensitive to 
DTx and B cells are resistant but cannot present antigens. During continuous 
cDC depletion, OT-II cells were still dependent on ICOS-ICOSL interactions 
to acquire CXCR5 expression during the initial stages of Tfh differentiation 
and cognate B interactions to fulfil Tfh development (Figure 7). Hence, 
generation of (OT-II) Tfh still depend on normal cellular and molecular 
interactions and administration of 3 mg of OVA in CD11c-DTR mice does not 
generate an antigen deposit that repopulating cDCs can utilize as a means to 
efficiently prime OT-II cells. 
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Addressing the role of other APCs in the absence of cDCs 
Since the necessity of cDCs could be mitigated when antigen is not limiting 
we set out address to role of other APCs in terms of T cell priming and Tfh 
induction proficiency. To approach this, we first identified MHCII expressing 
cells that express ICOSL as the ability to present antigen and provide ICOS-
ICOSL interactions is critical for Tfh induction (182). By this criteria, we 
observed that primarily Ly6Chigh monocytes,  but also pDCs, gained expression 
of ICOSL in response to polyI:C. Administration DTx in CD11c-DTR mice 
have been reported to result in blood neutrophilia (337) as well as deplete 
marginal zone macrophages (338) indicating that the APC landscape may be 
influenced in response to DTx. In addition to neutrophils we also observed an 
increased influx of Ly6Chigh monocytes suggesting that inflammatory 
monocytes may function as the primary APC after DTx mediated cDC 
depletion.  
Figure 8. Ly6C+ monocytes are complementary with B cells in driving CD4+ T cell 
expansion in the absence of cDCs. (A) CXCR5 expression and cell division by CFSE 
labelling d3 p.i. in CD11c-DTR mice with indicated treatment. (B) Total number of 
OT-II cells and CXCR5 expressing OT-II cells. 
Co-administration of DTx and aGR-1 antibodies in CD11c-DTR mice 
counteracted the influx of granulocytes and caused a partial reduction in 
Ly6Chigh monocytes compared to untreated animals but did not affect T cell 
priming or GC responses. Furthermore, GC responses remained intact after 
combined cDC, monocyte and pDC depletion by aPDCA-1 antibodies 
suggesting a possible redundancy between remaining Ly6Chigh monocytes and 
B cells in driving T cell expansion and Tfh differentiation. To delineate the 
roles of Ly6Chigh monocytes and B cells in terms of initial T cell priming we 
treated BMHCII-/- / CD11c-DTR mice with DTx in combination, or without, with  
aGR-1 and antibodies aPDCA-1. Strikingly, monocytes and pDCs in this 
system were able to support early T cell activation but in their absence T cells 
failed to robustly proliferate (Figure 8). These results suggest that in the 
absence of cDCs, Ly6Chigh monocytes along with B cells, and possibly pDCs, 
are capable of inducing T cell responses. Although B cells present more 
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peptide-MHCII complex when antigen dose is increased (294), B cells as sole 
APCs are poor inducers of T cell priming and Tfh differentiation in response 
to protein immunization and even in high peptide dose experiments (222). 
Thus, we cannot exclude an auxiliary role of residual Ly6Chigh monocytes after 
aGR-1 treatment in amplifying initial T cell expansion and supporting Tfh 
differentiation as they previously have been ascribed to perform this role (80) 
as long as functional B cells are present. 
 
Conclusions 
When high dose of antigen in the immunization is used: 
• cDCs are not required for robust T cell priming and Tfh 
differentiation.  
• monocytes and B cells, potentially also pDCs, can support 
early T cell priming and Tfh differentiation.  
• GC development, affinity maturation and memory responses 
still occur in the absence of cDCs 
• Th1 differentiation and associated IgG2c class-switch are 
drastically impaired in cDC depleted mice 
 
Paper II – Identification of genes regulated by B cells 
While cDCs are important, but not critical, for initial Tfh induction antigen 
presenting B cells is an absolute requirement for their complete differentiation 
and sustainment (222, 223). Given that the onset of Tfh differentiation marked 
by expression of CXCR5 and PD-1 can be initiated without the help of B cells 
(218, 223), the proposed model of Tfh differentiation is a step-wise interaction 
where the role of B cells is to propagate the Tfh differentiation pathway to 
generate GC Tfh cells. Although some co-stimulatory molecules provided by 
B cells like CD40 (225) and ICOSL (226) are known to be crucial for Tfh 
generation, the full extent of B cell influence on Th differentiation is not 
completely understood.  
Identification of genes in Th selectively regulated by B cells 
To address which genes in Th cells that are selectively regulated by B cells we 
opted for a wide and unbiased approach by MicroArray analysis of total OT-II 
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cells collected five days post a Th1 skewing immunization from mice in which 
B cells can present antigen or not. As expected in MHCIIB-/- mice, several Tfh 
associated genes, including Bcl6, c-Maf, Il21 and Cxcr4, showed a decline in 
expression that coincided with a loss of the CXCR5+ PD-1+ Tfh phenotype. 
Interestingly, we observed an adverse relationship between the expression of 
Il4 and the gene encoding for the IL-4 receptor, Il4ra, as well as a total loss of 
the gene H2-Q2 (Figure 9) which encodes a polymorphic non-conventional 
MHC class I molecule (339, 340). To address whether the dysregulation of Il4, 
Il4ra, and H2-Q2 seen in MHCIIB-/- mice was due to a loss of Tfh cells we 
sorted CD62L- CXCR5- and CD62L- CXCR5+ OT-II cells to be able to 
compare a bona-fide effector population to the follicular homing population. 
Indeed, the differential expression seen among total OT-II cells was restricted 
to CD62L- CXCR5+ OT-II cells. Furthermore, surface staining of IL-4Ra and 
intracellular cytokine staining for IL-4 confirmed that the expression of these 
genes was restricted to the CD62L- CXCR5+ population, suggesting that these 
genes were in fact related to Tfh cells. Moreover, in vitro re-stimulation of 
CD62L- CXCR5+ OT-II cells by agonistic aCD3 antibodies could not revert 
Il4ra or H2-Q2 expression back to levels seen in control mice, suggesting that 
these genes are not regulated by TCR signalling but rather by other co-
stimulatory signals provided by B cells.  
Figure 9. Genes regulated by B cells. (A-C) OT-II cells were sorted from MLNs of 
control and MHCIIB-/- mice 5 days p.i. with OVA + polyI:C. Gene expression of Il4 
(A), Il4ra (B) and H2-Q2 (C) relative to b-actin. 
Il-4 and IL4Ra expression in Tfh cells 
While production of IL-4 in Tfh cells have been reported by several studies 
(230, 237, 240), a concurrent downregulation or role of IL4Ra in Tfh biology 
have up until this point has not been described. First, we analysed the 
expression of IL4Ra in CXCR5-, CXCR5+ and CXCR5+ PD-1+ cells in OT-II 
cells as they developed following immunization. Although the three 
populations showed a decline in IL4Ra over time surface expression was 
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noticeably lower in Tfh cells at all time points. Given the close relationship 
between Th2 and Tfh cells (224, 237, 279), we speculated that the selective 
down regulation of IL4Ra in IL-4 producing Tfh cells could be a mechanism 
to circumvent autocrine IL-4 signalling by Tfh cells that otherwise could drive 
Th2 differentiation in Th1-skewed responses. In order to analyse IL4Ra 
expression among IL-4 producing cells in vivo we transferred KN2xOT-II cells 
that marks IL-4 secretion by surface expression of the hCD2 transgene (236). 
KN2xOT-II cells primed under Th1-skewing regimen showed a converse 
relationship between IL-4 secretion and expression of IL4Ra where active IL-
4 secretion was only detectable in Tfh cells (Figure 10). To dissect if this 
relationship between IL-4 and IL4Ra expression was selective for Th-1 biased 
immunizations or a general phenomenon we used the Th2 permissive adjuvant 
cholera toxin (CT) (341, 342). Analogous analysis in CT immunized mice 
showed similar results as polyI:C immunized mice. In addition, there was no 
evident difference in IL4Ra expression among IL-4-producing and non-
producing Tfh cells. These results show that IL4Ra downregulation and IL-4 
production are general features of Tfh cells regardless of adjuvant and IL-4 
secretion status. 
Figure 10. Differential expression of IL-4 and IL4Ra in different T cell populations. 
(A-B) KN2xOT-II cells in MLN 5d p.i. with OVA + polyI:C. (A) hCD2 expression in 
indicated populations. (B) Expression of hCD2 and IL4Ra in different T cell 
populations as gated in (A). 
 
To investigate if the downregulation of IL4Ra had any functionality in Tfh 
cells, we aimed to force expression in OT-II cells by transducing them with a 
retrovirus encoding IL4Ra. However, this experimental approach was 
unsuccessful as STAT5 signalling cytokines readily induce IL4Ra expression 
(131), most likely in response to autocrine IL-2 as a result of aCD28 co-
stimulation during in vitro activation (343). To counteract the upregulation of 
IL4Ra, we cultured in vitro activated OT-II cells in the presence of a 
neutralizing aIL-2 antibody to avoid IL-2 induced expression of IL4Ra. We 
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also adoptively transferred transduced OT-II cells into recipient mice to 
investigate if in vivo rest in the presence of natural survival signals would allow 
in vitro activated cells to downregulate IL4Ra expression. Regardless of 
stimulation conditions or extended in vivo rest, a difference in IL4Ra 
expression by the control-transduced cells was not discernible compared to 
cells expressing the IL4Ra construct. Hence, we could not generate a model 
system in which IL4Ra was differentially expressed during priming and forced 
to remain expressed during the GC reaction when IL-4 is produced by Tfh 
cells. Thus, we have not been able to address if the downregulation of IL4Ra 
serves as mechanism to shield Tfh cells from autocrine signaling or if it’s a 
means to increase IL-4 availability for GC B cells. 
Conclusions 
• Tfh cells produce IL-4 and downregulate its receptor, IL4Ra 
in a B cell dependent manner 
• The converse relationship between IL-4 secretion and IL4Ra 
expression in Tfh is not selective for Th1-biased adjuvants 
• At the transcript level in T cells, the expression of H2-Q2 
encoding for an unconventional MHCI molecule is regulated 
by B cells 
 
Paper III – B cells influence effector T cell output 
After T cell priming, Tfh cells and T effector cells develop in parallel governed 
by the transcription factors Bcl6 and Blimp-1 (170), respectively. We have 
previously described that early during the immune response developing Tfh 
cells and effector cells can be discriminated based on their exclusionary 
expression of the follicular homing receptor CXCR5 and the gut-tropic 
associated integrin a4b7 (268). While the signals that induce expression of 
CXCR5 in T cells still remain to be elucidated the vitamin A metabolite RA 
have been shown to induce a4b7 in T cells (270, 273). The expression of a4b7 
enables T cells to transmigrate from the blood into the SI LP by binding to 
MAdCAM-1 present on post-capillary venules along the SI. In a previous 
study we observed a population of T cells displaying co-expression of CXCR5 
and a4b7 (268). This suggested a conflict in homing preference between B cell 
follicle and gut. How these CXCR5+ a4b7+ T cells were generated and their 
peripheral homing capacity was not known. We speculated that these CXCR5+ 
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a4b7+ T cells may, at least partially, constitute former pre-Tfh cells that were 
not selected for GC entry. By combining thoracic duct cannulation and the OT-
II adoptive transfer system in mice in which B cells can or cannot present 
antigen, we set out to address if B cells play a role in the generation and output 
of gut homing a4b7+ Th cells.  
Figure 11.  Loss of cognate B cell interaction leads to an increase of effector T cells 
and a loss of Tfh cells. (A-B) OT-II cells in MLNs d5 p.i. of control or MHCIIB-/- mice 
that were immunized with OVA + polyI:C. (A) Facs plots showing the relationship 
between Bcl6 and a4b7. (B) a4b7 expression in T cell populations as determined by 
differential expression of CD62L and CXCR5.   
Antigen presenting B cells in T cell differentiation 
First, we addressed the generation of a4b7+ gut-tropic OT-II cells in control 
and MHCIIB-/- and observed an increase of total a4b7+ OT-II cells (Figure 
11A). This increment in a4b7+ was even further emphasized in B cell deficient 
µMT mice and accompanied by a loss of Tfh cells. By separating the T cells 
into four populations based on their expression of CD62L and CXCR5 it 
became clear that the increased expression of a4b7 was primarily concentrated 
to the CD62L- CXCR5+ population that also includes Tfh cells (Figure 11B). 
This suggests that prevention of Tfh cell development could lead to 
reprogramming into effector cells. In addition to a4b7 integrin, RA promote 
expression of the chemokine receptor CCR9 which further enhances the gut-
tropism by attracting T cell to CCL25 produced by SI epithelial cells (38). 
Although there was an evident increase in CCR9 expression among both 
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CD62L- CXCR5- and CD62L- CXCR5+ OT-II cells in the MLN, no increase in 
OT-II cells was observed in the SI LP. Moreover, there was no bias towards 
CCR9+ OT-II in the SI LP despite their increased generation in MLN. 
Characterization of CD4+ T cells that have left the LN 
The apparently unaltered SI entry of Th in MHCIIB-/- mice could potentially 
mean that the newly generated effector cells remained in the MLN, possibly 
by virtue of their CXCR5 expression. Alternatively, transmigration over the 
endothelium is a rate-limiting event that is saturated in our adoptive transfer 
model. To faithfully study Th cells that have left the LN we cannulated the 
thoracic duct and collected TDLs. To our knowledge emigrant CD4+ T cells in 
TDL have not previously been studied. We therefor assessed the phenotype of 
recent emigrant T cells at various time-points post immunization in wt mice 
and used MLN as a reference SLO. Although TDLs contain T cells primed in 
all lower limbs it became clear that egress from gut draining LNs constitute the 
major part of TDLs as approximately 80% of all OT-II cells expressed a4b7 
day 3 p.i. (Figure 12A). This is in line with a previous study in our group using 
FTY720 to block LN output showing that during the first 3 days of the immune 
response LN egress is dominated by a4b7+ cells (268). Moreover, most of the 
a4b7 expressing TDL OT-II cells co-expressed CCR9, a clear enrichment 
compared to the MLNs (Figure 12B). At this time point, Tfh cells in the MLN 
can be identified by high expression of PD-1 or Bcl6 coupled to CXCR5 
expression. However, the Tfh population during this time point is confined to 
the a4b7- OT-II cell compartment. Indeed, cells exhibiting a Tfh profile day 3 
p.i. could not be seen among TDLs, indicating that Tfh cells remain in the 
MLN at this stage (Figure 12C). 
 
 
Figure 12. Early LN output consists of effector cells. (A-C) Phenotypic analysis of 
OT-II cells in TDL d3 p.i. after OVA + polyI:C. (A-B) Expression of a4b7 (A) and 
frequency of CCR9+ cells of  a4b7+ cells (B). (C) Representative contour plots showing 
CXCR5 and PD-1 expression in MLN and TDL.   
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Identification of ex-Tfh cells migrating in lymph 
Next, we sought to address whether the CXCR5+ a4b7+ population evident at 
later time points (268) was migratory in its nature. At day 5 p.i. the egress of 
a4b7+ as well as CCR9+ had waned and the OT-II cells in TDL showed a 
remarkable resemblance to those in MLN in terms of a4b7 and CCR9 
expression. Interestingly, we observed migratory populations exhibiting the 
characteristic CXCR5+ PD-1+ Tfh phenotype, albeit with a slightly lower 
expression of PD-1 compared to MLN, in both a4b7+ and a4b7- OT-II cells. 
This indicates that former Tfh cell (ex-Tfh) do exit LNs early during the 
immune response. However, ex-Tfh cells among TDLs showed an almost 
complete loss of Bcl6 expression suggesting that either these cells never fully 
committed to the Tfh differentiation pathway or that Bcl6 is downregulated 
before LN egress. A previous study reported that blood CXCR5+ PD-1int T cells 
corresponded to circulating Tfh-memory cells (344). The generation of these 
cells was shown to dependent on Bcl6 and ICOS sufficiency but independent 
of SAP signalling. This suggests that CXCR5+ PD-1int T cells are generated 
and egress before GC formation. To test whether CXCR5+ PD-1+ OT-II TDL 
cells were generated independently of GCs we performed thoracic duct 
cannulation in control and MHCIIB-/- mice. Consistent with our initial findings 
that a4b7+ and CCR9+ gut-tropic effector cells are abundantly generated in the 
MLN of MHCIIB-/- mice, a4b7 and CCR9 expressing OT-II cells are also more 
prevalent among TDLs of MHCIIB-/- mice compared to control (Figure 13A-
B). Moreover, CXCR5+ PD-1+ ex-Tfh cells are exclusively found in TDLs 
from control mice regardless of a4b7 expression or not (Figure 13C). He et al 
showed that the generation of blood CXCR5+ PD-1int cells was independent of 
long lasting B cell interactions at later time points (344). This suggests that the 
presence of migrating ex-Tfh could be dependent on kinetics. Thus, we 
collected TDLs from control and MHCIIB-/- mice at day 8 p.i. when GC are 
fully established in control animals but absent in MHCIIB-/- mice and found that 
ex-Tfh were absent in TDLs of both groups. This shows that egress of ex-Tfh 
displaying the bona-fide CXCR5+ PD-1+ Tfh phenotype is an early event and 
that migratory ex-Tfh cells are generated in a B cell dependent manner.  
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The reason why these ex-Tfh cells opt to migrate is unclear, one possibility 
could be that Tfh cells are generated in abundance relative to what is needed 
to generate an optimal GC response and therefore some Tfh cells are forced to 
leave by competition. A recent study has demonstrated that Tfh-memory cells 
with high affinity TCRs remain in the reactive LN after resolution of the GC 
response whereas low affinity Tfh clones migrate to non-reactive LNs to serve 
as memory cells (285). Due to our model system of tracking transgenic OT-II 
we cannot determine if TCR affinity regulates the output of ex-Tfh cells. 
However, the vast difference in kinetics between the model systems and our 
finding that a fair share of ex-Tfh express a4b7 and have downregulated 
CD62L, hallmarks of gut-tropic effector T cells, implies that we are not 
studying disseminating memory Tfh cells bound for LNs. 
Figure 13. Loss of cognate B cell interaction increases output of effector cells.     (A-
C) OT-II cells were adoptively transferred into control or MHCIIB-/- mice that were 
cannulated d4 p.i. Expression of a4b7 (A) and frequency of CCR9+ cells of  a4b7+ 
cells (B). (C) Identification of a4b7+ Tfh cells in TDL of control and MHCIIB-/- mice. 
ex-Tfh cells have a history of IL-4 secretion  
Since the ex-Tfh population was dependent on cognate B cell interaction for 
their generation, we wanted to examine whether ex-Tfh cells had participated 
in the GC reaction before migrating or if they were selected for LN egress at 
the initial T-B interaction in the interfollicular region. To address this we 
exploited the KN2xOT-II mouse model in which IL-4 secretion can be 
monitored for at least 24h by surface expression of hCD2 (236). As seen in 
paper II, as well as other studies (237, 238), secretion of IL-4 in SLOs is 
restricted to the Tfh population (though not all Tfh cell produce IL-4). We 
therefore used hCD2 expression as a retrospective marker of GC history. 
Tracking of recent emigrant KN2xOT-II cells in TDLs revealed that former 
IL-4 secreting cells are present among both a4b7+ gut-tropic and a4b7-  
KN2xOT-II cells. Furthermore, within the a4b7+ KN2xOT-II compartment in 
MLN and TDL the surface expression of hCD2 was restricted to the CCR9- 
cells. Even though CCR9 and hCD2 expression was mutually exclusive in 
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MLN and TDL hCD2 expression was also clearly evident among CCR9+ 
KN2xOT-II cells in the SI LP (Figure 14A).  
Figure 14. ex-Tfh cells have a history of IL-4 secretion. (A-C) KN2xOT-II cells were 
transferred into wildtype (A) or control and MHCIIB-/- chimeras (B-C) and analysed 
for hCD2 and IL4Ra expression day 5 p.i.. (A) Representative flow cytometry plots 
showing CCR9 versus hCD2 expression on KN2xOT-II cells in MLN, TDL and SI LP. 
(B-C) Analysis of hCD2 (B) and IL4Ra (C) expression in CCR9+ (left panels) and 
CCR9- (right panels) KN2xOT-II cells in SI LP. 
This finding was seemingly confusing and could possibly be explained by 
either upregulation of CCR9 by hCD2+ cells or that CCR9+ cells start to secrete 
IL-4 upon arrival into the effector tissue. Other studies using the KN2 model 
combined with a hCD4 reporter for IL-13 secretion have reported that Th2 
effector cells produce IL-4 and IL-13 in SLOs but do not secrete these 
cytokines until arrival in the effector tissue (238). Hence, we speculated that 
hCD2+ CCR9+ KN2xOT-II cells in the SI LP were not ex-Tfh cells but rather 
an IL-4 producing effector cell generated under Th1-polarizing conditions. In 
particular, Tfh and IL-4 producing Th2 cells have a close relationship as their 
development seems to be intertwined although IL-4 competent T cells can be 
generated in the absence of B cells (224, 279). To distinguish CD4+ T cells that 
secreted IL-4 in a B cell dependent manner from bona-fide effector cells we 
adoptively transferred KN2xOT-II cells into control and MHCIIB-/- chimeras. 
Although PD-1 expression was lost at day 5 p.i. in MHCIIB-/- chimeras we were 
able to detect remaining Bcl6 expression identifying cells that once were 
poised to become Tfh cells. However, only CXCR5+ Bcl6+ cells in control 
animals showed a history of IL-4 secretion, indicating that pre-Tfh cells do not 
actively secrete IL-4 before antigen is presented by B cells. When analysing 
hCD2 expression (IL4 secretion) by KN2xOT-II cells in the SI LP it became 
clear that the CCR9+ population was unaffected in MHCIIB-/- mice whereas 
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hCD2 expression was drastically reduced among CCR9- cells (Figure 14B). In 
line with paper II but not shown in paper III, we also analysed expression of 
IL4Ra in OT-II cells from SI LP. This analysis revealed that CCR9- expressed 
lower levels of IL4Ra compared to CCR9+ cells. This reduced expression was 
annulled in MHCIIB-/- mice (Figure 14C) which further supports that CCR9- 
OT-II cells in the SI-LP have interacted with B cells. Collectively, our data 
show that ex-Tfh cells, by expression of a4b7 and IL4 secretion history, can 
be traced from the MLN via circulation into the SI LP where they, at least 
partially, make up the CCR9- population (Figure 15). If these cells have a 
particular function in mucosal immune homeostasis, possibly by unique 
cytokine production or by supporting B cells in isolated lymphoid follicles, 
merits further research. 
 
Conclusions 
• Gut-tropic effector cells are generated at the expense of Tfh 
cells in the absence of cognate B cell interaction 
• Five days p.i. ex-Tfh cells emigrate from the lymph node and 
some express markers associated with mucosal homing 
• Migratory ex-Tfh cells that have interacted with B cells, 
traced by IL-4 secretion are able to home to the SI LP 
• Eight days p.i. ex-Tfh cells in TDL can no longer be identified 
by CXCR5 and PD-1 expression  
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Figure 15. Graphic summary of ex-Tfh and T effector migration
 60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TL:DR: The immune system is complex 
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